#  @BiotechCH Biotech Hangout Biotech Hangout posts on X about $lly, $amgn, ipo, $nvs the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours. ### Engagements: [-----] [#](/creator/twitter::1353752829266194434/interactions)  - [--] Week [------] -20% - [--] Month [------] +70% - [--] Months [-------] -5.70% - [--] Year [-------] +10% ### Mentions: [--] [#](/creator/twitter::1353752829266194434/posts_active)  - [--] Month [--] -35% - [--] Months [---] +1.40% - [--] Year [---] -24% ### Followers: [------] [#](/creator/twitter::1353752829266194434/followers)  - [--] Week [------] +0.19% - [--] Month [------] +1.50% - [--] Months [------] +8% - [--] Year [------] +19% ### CreatorRank: [-------] [#](/creator/twitter::1353752829266194434/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 59.82% [finance](/list/finance) 25.89% [cryptocurrencies](/list/cryptocurrencies) 14.29% [countries](/list/countries) 8.04% [currencies](/list/currencies) 6.25% [technology brands](/list/technology-brands) 2.68% [social networks](/list/social-networks) 0.89% [exchanges](/list/exchanges) 0.89% [vc firms](/list/vc-firms) 0.89% [financial services](/list/financial-services) 0.89% **Social topic influence** [$lly](/topic/$lly) 10.71%, [$amgn](/topic/$amgn) #89, [ipo](/topic/ipo) #849, [$nvs](/topic/$nvs) 9.82%, [sentiment](/topic/sentiment) #1167, [ceo](/topic/ceo) 8.04%, [$vrtx](/topic/$vrtx) 8.04%, [china](/topic/china) 7.14%, [$azn](/topic/$azn) 6.25%, [$mrk](/topic/$mrk) 6.25% **Top accounts mentioned or mentioned by** [@daphnezohar](/creator/undefined) [@bradloncar](/creator/undefined) [@timopler](/creator/undefined) [@cngarabedian](/creator/undefined) [@samfazeli8](/creator/undefined) [@ericschmidt151](/creator/undefined) [@biotech1](/creator/undefined) [@yaronwerber](/creator/undefined) [@jschimmere](/creator/undefined) [@jmaraganore](/creator/undefined) [@matteispaul](/creator/undefined) [@brianskorney](/creator/undefined) [@lifescivc](/creator/undefined) [@thedawnbell](/creator/undefined) [@colongracee](/creator/undefined) [@tlorriman](/creator/undefined) [@lubagreenwood](/creator/undefined) [@mpreminger](/creator/undefined) [@soowannaway](/creator/undefined) [@seals310](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Amgen, Inc. (AMGN)](/topic/$amgn) [Novartis AG (NVS)](/topic/$nvs) [Vertex Protocol (VRTX)](/topic/$vrtx) [AstraZeneca PLC (AZN)](/topic/$azn) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Johnson & Johnson (JNJ)](/topic/$jnj) [AbbVie Inc (ABBV)](/topic/$abbv) [GSK plc (GSK)](/topic/$gsk) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Biogen Inc (BIIB)](/topic/$biib) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Synthetify (SNY)](/topic/$sny) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [Janux Therapeutics, Inc. (JANX)](/topic/$janx) [Moderna Inc (MRNA)](/topic/$mrna) [Immunogen Inc (IMGN)](/topic/$imgn) [4D Molecular Therapeutics Inc. (FDMT)](/topic/$fdmt) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Seagen Inc (SGEN)](/topic/$sgen) [Verve Therapeutics Inc. (VERV)](/topic/$verv) [Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP)](/topic/$hznp) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Pliant Therapeutics, Inc. (PLRX)](/topic/$plrx) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Illumina, Inc. (ILMN)](/topic/$ilmn) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Recursion Pharmaceuticals, Inc. (RXRX)](/topic/$rxrx) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Novo-Nordisk (NVO)](/topic/$nvo) [Mirati Therapeutics, Inc. Common Stock (MRTX)](/topic/$mrtx) [Olema Pharmaceuticals, Inc. (OLMA)](/topic/$olma) ### Top Social Posts Top posts by engagements in the last [--] hours "$PFEs and $MTSR GLP-1 and $AMGNs investigational MariTide programs shared clinical data. Whats encouraging is that both are reaffirming each other's data says @YaronWerber. We actually think both the $AMGN program and potentially this program are going to look very viable. And the KOL feedback has really turned the corner from being a little confused upfront to being fairly interested and supportive. #BiotechHangout https://twitter.com/i/web/status/2019832188691157472 https://twitter.com/i/web/status/2019832188691157472" [X Link](https://x.com/BiotechCH/status/2019832188691157472) 2026-02-06T17:54Z 15.9K followers, [---] engagements "Good morning to our 20k followers on Clubhouse Its exciting to see how the community in @joinClubhouse continues to grow. Hope to see you soon Android users" [X Link](https://x.com/BiotechCH/status/1381242084213030917) 2021-04-11T13:45Z 15.9K followers, [--] engagements "We asked on our last show what is the track record of short sellers. Elliot Favus sent us his closed positions. Copied below with permission in multiple tweets. Shared without endorsement or comment" [X Link](https://x.com/BiotechCH/status/1708446936129311104) 2023-10-01T11:41Z 15.9K followers, 75.5K engagements "On todays #BiotechHangout @cngarabedian @BrianSkorney and @SamFazeli8 will kick off with general market sentiment & green shoots for biotech plus public & VC markets deals/financings: $ALKS/$AVDL $2.1B deal for #narcolepsy drug $SMMTs $500M raise w/ 50% insiders $ANRO & $NRIX financings $TAK-Innovent $1.2B upfront cancer drug deal #ESMO2025 recap: Tubulis data + $361M Series C $SMMT/Akeso Exelixis $INCY $JNJ impact on $MRUS/$GMAB/$BCAX/$CRBP TIGIT updates ($RCUS+ $AZN) & more highlights plus other data news & stock reactions: $ALEC/$GSK #dementia drug $VTYX cardio data $ARCT cystic fibrosis" [X Link](https://x.com/BiotechCH/status/1981707275011072506) 2025-10-24T13:00Z 15.9K followers, 10.1K engagements ".@YaronWerber dives into the $GILD and $ACLX data coming out of #ASH with anito-cel emerging as a potential best-in-class BCMA CAR-T for relapsed/refractory multiple myeloma: $JNJ and $LEGN have been the leaders for BCMA in myeloma. Their efficacy has been absolutely tremendousbut they do have some noticeable toxicity and it causes low rates of Parkinsonism The drug from $GILD $ACLX does not cause any of this toxicityWhen anito-cel comes to market next year because it's safer and it doesn't have any of these issues it's really going to be probably the preferred drug. It's really going to have" [X Link](https://x.com/BiotechCH/status/1999541599831761353) 2025-12-12T18:07Z 15.9K followers, [---] engagements "On todays #BiotechHangout @SamFazeli8 @MatteisPaul @BrianSkorney & @t_lorriman will covermarket sentiment: $XBIs wobbly start& rebound on M&A news ahead of #JPM26politics:pediatric vaccine updates deals:M&A fundraisings & the firstIPOfiling to open the window $AZN/Jacobio deal $ABBV & $RVMD rumors plus data: $CRNX Palsonify launch & CAH clinical study $ZBIOtopline data for IgG4related disease $RAREs setrusumab update obesity news ($NVOs oral pill & $ARWR RNAi-based drug) $SNYs tolebrutinib CRL & pipeline outlook $NMRAsreadouts & $GHRSclinical hold lifted & preps for Ph3 $ALMS Ph3 psoriasis" [X Link](https://x.com/BiotechCH/status/2009626428359294983) 2026-01-09T14:00Z 15.9K followers, [----] engagements ".@MatteisPaul weighs in on $NMRAs oral Alzheimers agitation drug NMRA-511 that has shown some success in Phase 1b reducing agitation without sedation: The study showed a small trend for their drug versus placebo on an agitation scale. Alzheimer's agitation is a huge medical need that is super tough to treat. Really hard to have a drug that can help patients feel less agitated but also thread the needle on side effects like somnolence and sedationI would say from being someone who's followed a lot of these psychiatry readouts over the years and has gotten excited about things that look" [X Link](https://x.com/BiotechCH/status/2009690438203043849) 2026-01-09T18:15Z 15.9K followers, [---] engagements "Big deal news: $GSK is paying $2.2B to acquire $RAPT betting on its Phase [--] anti-IgE antibody ozureprubart as a next-gen food allergy contender vs. Xolair. Its very strategic for $GSK as they have quite a nice presence in the immunology spacea very good deal to keep the M&A train going for biotech says @soowannaway. "That asset is coming from China in a transaction that consummated in Dec. '24 and $RAPT paid only $35M upfront for this asset. So great turn of events for this company. They've not done anything with this asset since in licensing it a little over a year ago. The Chinese company" [X Link](https://x.com/BiotechCH/status/2014757667412046116) 2026-01-23T17:50Z 15.9K followers, [---] engagements "Another notable oncology deal: $JANX struck a collaboration and exclusive worldwide license with $BMY to develop a tumor-activated therapy for solid tumors. $JANX is a really interesting companythe stock has come down a lot on some disappointment around some of their lead programs. I do think the $BMY deal this week is a big vote of confidence in the platform says @TimOpler. #BiotechHangout https://twitter.com/i/web/status/2014759109396947041 https://twitter.com/i/web/status/2014759109396947041" [X Link](https://x.com/BiotechCH/status/2014759109396947041) 2026-01-23T17:56Z 15.9K followers, [---] engagements "The area that $JANX plays in is masked bispecific antibodies for oncology says @EricSchmidt151. There are a couple other firms in the space too that are developing the ability to have these masked antibodies. They're only activated within the tumor microenvironment. So the idea here is that you can bring the benefit of an efficacious T cell-directed therapy to a cancer antigen without having the negativity of engaging those T cells outside of the tumor mass and triggering cytokine release syndrome or other inflammatory mechanisms. It's a foundational and fundamentally interesting tool. Again" [X Link](https://x.com/BiotechCH/status/2014759374728708349) 2026-01-23T17:57Z 15.9K followers, [---] engagements "On this weeks #BiotechHangout @biotech1 (Josh Schimmer) @SamFazeli8 @BrianSkorney @YaronWerber are joined by @IAmBiotechs John Crowley to discuss latest perspectives on happenings&tone in D.C.: whats next with MFN FDA updates biotech race w/China($AZN $15B mfg. investment in China & $1.2B upfront deal w/CSPC) latest IRA list plusmarket sentiment:growing number of high-quality private companies & potential IPO feeding frenzy$IBB hittingnewhighswhile$XBIlags investor sentiment survey Eikon ($EIKN)IPO filing deals & investments: $MRK ends $RVMD dealtalks $RGNX clinical hold $MRNAs upcoming" [X Link](https://x.com/BiotechCH/status/2017236501344530494) 2026-01-30T14:00Z 15.9K followers, 10.5K engagements "$MRK is no longer in discussions to buy $RVMD after failure to agree on price. The interesting part is that $RVMD doesn't need it. They've got great assets great data set coming out says @SamFazeli8. They've got data coming this year that could potentially change the landscape in pancreatic cancer and they have plenty of cash. They have just done a deal with Royalty Pharma and more money is available to them if they need to draw downSo it's probably a company that will eventually be attractive to a pharma company at some point. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/2017295733133873633) 2026-01-30T17:55Z 15.9K followers, [---] engagements "$AMGN resists an FDA request to pull Tavneos. The agency has flagged data from a [----] $CCXI trial: This drug has a long historyThe data were always kind of mixed. It looked like there was some activity there but through even Phase [--] and then Phase [--] studies the drug never quite was able to achieve I'd say a clearly positive result says @EricSchmidt151. #BiotechHangout https://twitter.com/i/web/status/2019827407415357762 https://twitter.com/i/web/status/2019827407415357762" [X Link](https://x.com/BiotechCH/status/2019827407415357762) 2026-02-06T17:35Z 15.9K followers, [---] engagements "The FDA has signaled that it will go after mass compounders such as $HIMS. Good for Dr. Makary. If you look up what compounding pharmacies are supposed to be doing this is the exact opposite says @EricSchmidt151. They're supposed to be filling unmet medical niches right Taking drugs that are out there at different strengths or formulations and adjusting them to fit patients' needs where there are no commercializable therapiesHims and Hers is using their status as a compounding pharmacy to try and essentially get in the back door and rip off someone's IP. So I applaud the FDA for standing tall" [X Link](https://x.com/BiotechCH/status/2019831140329075170) 2026-02-06T17:50Z 15.9K followers, [---] engagements "Fun fact: this year marks [---] years since the discovery of insulin Identified in [----] insulin was first used to treat Type [--] Diabetes in January [----]. Thank you to Felicia Pagliuca for setting the stage to talk about @VertexPharmas T1D research" [X Link](https://x.com/BiotechCH/status/1452374594145292288) 2021-10-24T20:41Z 15.9K followers, [--] engagements "On todays #BiotechHangout @cngarabedian @Seals310 (Mike Yee) @MatteisPaul and @SamFazeli8 willrecap #JPM26 & market sentiment: [----] kickoffandM&Aandfinancing vibe this year state of VC investingcompany updates: $ALNY [----] updates & stock reactions $MRNA news & price auction deals: $ABBVs $650M PD1/VEGF deal w/ China AI partnerships regulatory: FDA guidance on cell & gene therapies plus $ATRAs CRL FDA CNPV voucher updates obesity: $LLY awaits FDA approval $AMGNs data & controversy big pharmaobesity hunt($ABBV & $BMY) other data: $LXEO PKP2 results $BMRN DMD exon skipping data & no safety" [X Link](https://x.com/BiotechCH/status/2012171524074008619) 2026-01-16T14:34Z 15.9K followers, [----] engagements "$ALNY has unveiled their Alnylam [----] strategy where they lay out plans to scale global TTR leadership invest in transformative RNAi therapies and target $4.9-$5.3B in [----] revenues: We thought that maybe this [----] guide is not as much of a reach as others think said @MatteisPaul. We still felt like the update here from a fundamental perspective is still overall positive as it relates to the TTR franchise and the fact that they're going to be spending 30% of revenues on R&D. So you have to believe with four INDs a year they're going to get more meaningful drugs coming out of this companyI" [X Link](https://x.com/BiotechCH/status/2012217708880830738) 2026-01-16T17:37Z 15.9K followers, [---] engagements "On todays #BiotechHangout @soowannaway (Graig Suvannavejh) @cngarabedian @EricSchmidt151 & @YaronWerber will cover market sentiment &IPO reception this week ($MANE $EIKN Generate Bios S-1 filing) $AMGNs refusal to pull rare disease drug at FDAs requestpolicy: rare PRV reauthorizationto [----] $CMPS psychedelic FDA PRV / WH rejection @NEJM article on Medicare drug pricing negotiations $AQST stock trading up on CRL obesity news: $HIMS launch of semaglutide pill & FDA response$PFE/$MTSR data plusothercompany news: $GSK returning rights to $WAVE for rare disease drug $UPBs upcoming Ph2 asthma data" [X Link](https://x.com/BiotechCH/status/2019773921298448754) 2026-02-06T14:03Z 15.9K followers, [----] engagements "https://x.com/i/spaces/1lDGLBlpqMaxm https://x.com/i/spaces/1lDGLBlpqMaxm" [X Link](https://x.com/BiotechCH/status/2019817991878459746) 2026-02-06T16:58Z 15.9K followers, [----] engagements "Kicking off todays show the hosts dive into a big week for IPOs headlined by $MANE and $EIKN: It looks like we are going to see a pretty healthy year with maybe six or seven IPOs priced in the first six weeks of the year says @EricSchmidt151. We're inundated with interest from private companies looking to potentially test this window. So as we've talked about before this could be a very very robust year in terms of numbers. #BiotechHangout https://twitter.com/i/web/status/2019821866139914312 https://twitter.com/i/web/status/2019821866139914312" [X Link](https://x.com/BiotechCH/status/2019821866139914312) 2026-02-06T17:13Z 15.9K followers, [---] engagements "Flagship-backed Generate Biomedicines has filed for an IPO based on an AI and in silico antibody engineering platform. They're partnered with Amgen. They're partnered with Novartis. They have really impressive capabilities in labs says @YaronWerber. This is going to be a high quality one. Of course these are going to be areas with a lot of competitors. So that's the one thing to watch. #BiotechHangout https://twitter.com/i/web/status/2019825700971205000 https://twitter.com/i/web/status/2019825700971205000" [X Link](https://x.com/BiotechCH/status/2019825700971205000) 2026-02-06T17:29Z 15.9K followers, [---] engagements "On today's #BiotechHangout @ColonGraceE @cngarabedian @SamFazeli8 @MatteisPaul @YaronWerber and special guest @johnbstanford will cover policy: NDAA provisions & implications for biotech industry trends & deals:big Monday w/ $1.85B inbiotech financings most in one day $XBIs sustained momentum & positive signals $LLYs acquisitive strategyplusFosun+$PFEdealfor oral GLP-1 conferences: #ASH2025 ($AZN $LLY vs $ONC$JNJ/$LEGN vs $GILD/ACLX $GMAB $TERN) #ESMOAsia25 ($BNTX Zelgen $GSK &otherADCs) $CGON at #SUO25 plus other data: $DYN positive DMD data obesity news ($GPCR $WVE Ascletis) Endpoints 100" [X Link](https://x.com/BiotechCH/status/1999488531844989310) 2025-12-12T14:36Z 15.9K followers, 10.9K engagements "On todays #BiotechHangout @ColonGraceE @TimOpler @soowannaway (Graig Suvannavejh) & @EricSchmidt151 will cover market sentiment: [----] biopharma market outlook a bull/bear debate on the sector companies gearing up for IPOs are we ready deals: $GSKs $2.2B acquisition of $RAPT $JANX / $BMY $850M deal policy: US exits the WHO latest biotech funding bill topics FDAs MRD-negative guidelines for myeloma company news: $CRVS Ph1 atopic dermatitis data (stock jump & competitive landscape) plus @TimOplers womens health report & much more: https://twitter.com/i/spaces/1PlJQOplrNZKE" [X Link](https://x.com/BiotechCH/status/2014716201184727341) 2026-01-23T15:05Z 15.9K followers, [----] engagements "$GSK returns rights to $WAVEs lead rare disease candidate WVE-006 for alpha-1 antitrypsin deficiency. What's interesting about this is that the reason was given that this might be too small of a market for $GSK but this is one of the larger rare diseases says @cngarabedian. Now having said that there's a new CEO that came into $GSK taking over from Emma Walmsley so that there's always those changes that come with a new CEOSo again it's just an interesting thing to watch for. Where is pharma prioritizing or not prioritizing Because investors need to understand who the natural acquirers for" [X Link](https://x.com/BiotechCH/status/2019835100775530836) 2026-02-06T18:06Z 15.9K followers, [---] engagements "On todays #BiotechHangout @cngarabedian @t_lorriman @EricSchmidt151 @SamFazeli8 & @bradloncar cover deals/financing: $LBRX IPO (first since Feb) $TRML acquisition policy: the latest in China biotech: Washingtons response deals under scrutiny & stakeholder pushback plus the Trump administrations attack on direct-to-consumer marketing $RNA data + secondary offering #WCLC25: big share price moves & data from $SMMT $RVMD & $TIL $RVMD 1L PDAC $DNTH positive gMG data regulatory: FDA pulls $ICPTs liver drug Capsida gene therapy death FAERS report & impact on $SLNO SEC vs. $FGEN CMO $CAPRs letter to" [X Link](https://x.com/BiotechCH/status/1966487219943723412) 2025-09-12T13:01Z 15.9K followers, 15.2K engagements "#BiotechHangout is taking a break this week for Presidents Day weekend & will return on Friday Feb. [--] at 12pm ET. While were away stream the latest episodes on Spotify Apple Podcasts Amazon Music YouTube & We hope you enjoy the long weekend with friends & family http://BiotechHangout.com http://BiotechHangout.com" [X Link](https://x.com/BiotechCH/status/2021918547580948988) 2026-02-12T12:05Z 15.9K followers, [---] engagements "On Friday's #BiotechHangout @robperez32 joins @DaphneZohar & @JSchimmer_E to discuss the week's deals data & FDA actions w/ guests @AlexHarding7 & DiCE CEO @KevinJudice. Tell us if there's a topic you'd like us to cover below & tune in at 3pm ET https://x.com/i/spaces/1MYGNgRqRVvJws=20 https://x.com/i/spaces/1MYGNgRqRVvJws=20" [X Link](https://x.com/BiotechCH/status/1583090033019404288) 2022-10-20T13:37Z 15.9K followers, [--] engagements "Tune in for #BiotechHangout this Friday at 3pm ET when @LifeSciVC @TimOpler & @DaphneZohar will cover the week in biotech & special guest Michael Yee will discuss why BAMG is the new FAANG & how generalists are now favoring big #biotech/#pharma https://x.com/i/spaces/1OwxWwggabRxQs=20 https://x.com/i/spaces/1OwxWwggabRxQs=20" [X Link](https://x.com/BiotechCH/status/1588157147459846144) 2022-11-03T13:12Z 15.9K followers, [--] engagements "Today's #biotechhangout w/ @SamFazeli8 & @TheDawnBell. #Biotech priorities (patients/investors/incentives) single product cos ( $OYST & $ACOR) $EQRX pricing model $BIIB $SGEN CEOs $GSK $MACK #oncology & what endpoints matter $VERV $CLVS $ARWR + @LifeSciVC YE review" [X Link](https://x.com/BiotechCH/status/1591109101014388736) 2022-11-11T16:42Z 15.9K followers, [--] engagements "Today @LifeSciVC @jmaxlevin @eperlste join @DaphneZohar/@JSchimmer_E to chat #Jefferies22 @a16z's "Biggest Company" deals/financings: $ACRV $NTRA $OPNT/ $INDV $LNTH/ $POINT FDA/clinical updates: $IMGN $PRVB $EDIT $ARDX perspectives on CEOs & politics etc #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1593659269869608960) 2022-11-18T17:35Z 15.9K followers, [--] engagements "We're back this Friday with @mpreminger @daphnezohar and @JSchimmer_E. @JacobPlieth will join as a special guest to talk all things #CTAD22 #oncology (#ASH22 $AZN $GSK) and more. Don't miss it #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1598002762134212609) 2022-11-30T17:15Z 15.9K followers, [--] engagements "Busy #BiotechHangout today @JebKeiper joins to discuss his $6B $TAK deal. @JSchimmer_E @daphnezohar @cngarabedian @timopler will talk M&A deals/financings ( $HZNP/ $AMGN $THRD $SIOX $ORTX) data (#ASH22 $ACET $AFMD $FATE $ALLO $CRBU $MRNA/ $MRK) & FDA w/ @RealEndptsMel" [X Link](https://x.com/BiotechCH/status/1603792154756890625) 2022-12-16T16:40Z 15.9K followers, 11.1K engagements "Our #tweetup event #JPM23 is open to everyone in #biotech community. We recall embarrassing early career snubs from crashing closed JPM events (one of us was shamed by the CEO of a PR firm at her famous party). Reply w/your own story & we'll commiserate & share the best ones 🗣 Hey everyone the #Tweetup is moving to Tuesday this #JPM23. Its for everybody and we hope to see you there. Thanks to our sponsors @PureTechh @BankPacWest @misprobiotech @FTIConsulting @CoulterPartners Emerald Bioventures @MassBio RSVP here: https://t.co/YhMRsIlwRu https://t.co/TdJhCXXLCg 🗣 Hey everyone the #Tweetup" [X Link](https://x.com/BiotechCH/status/1610328332628811778) 2023-01-03T17:32Z 15.9K followers, 23.2K engagements "We hope to see you next Tuesday at our #JPM23 #BiotechHangout #tweetup. Then @bradloncar & @cngarabedian will join us Friday 1/13 to recap RSVP: https://bit.ly/3FPAIyq https://bit.ly/3FPAIyq" [X Link](https://x.com/BiotechCH/status/1611470731526934528) 2023-01-06T21:12Z 15.9K followers, [----] engagements "#JPM23 scavenger hunt. If you see these people anywhere in San Fran (or en route) take a pic w/ them & tag us. Win bragging rights & gift cards. Winners announced Tuesday night at the #tweetup. Rules here:" [X Link](https://x.com/BiotechCH/status/1612089110348398593) 2023-01-08T14:09Z 15.9K followers, 65.1K engagements "Great turnout at the #tweetup #jpm23" [X Link](https://x.com/BiotechCH/status/1613018196193464322) 2023-01-11T03:41Z 15.9K followers, 11.5K engagements "Congrats to our #BiotechHangout #JPM23 Scavenger Hunt winner @ashokamadduri who knocked it out of the park w/ @VasNarasimhan @DrCaliff_FDA @rickberke @ldtimmerman @bradloncar + more Honorable mentions go to @TheDawnBell & @mpreminger who didnt do too shabby either" [X Link](https://x.com/BiotechCH/status/1613242397198016530) 2023-01-11T18:32Z 15.9K followers, [----] engagements "Thank you to everyone that made it out to the #BiotechHangout #Tweetup event in San Francisco last night It was wonderful to see so many friends from the #biotech community. #JPM23" [X Link](https://x.com/BiotechCH/status/1613262655409557504) 2023-01-11T19:52Z 15.9K followers, 10.7K engagements "We talk #JPM23 news & sentiment w/ @DaphneZohar @JSchimmer_E @BradLoncar @ChrisGarabedian today: deals/financings #biotech stock performance [--] cos. pre-announce Q4 results (new trend) data FDA requires less animal work & halts more human trials + Brad TV #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1613956402954764304) 2023-01-13T17:49Z 15.9K followers, 20.6K engagements "Fidelitys Rajiv Kaul @LifeSciVC @TheDawnBell & @TimOpler join @daphnezohar at 3pm ET today to discuss industry sentiment & their approaches to assessing ideas. Will also cover deals financings data & FDA news. #BiotechHangout https://x.com/i/spaces/1dRKZMqEovXxBs=20 https://x.com/i/spaces/1dRKZMqEovXxBs=20" [X Link](https://x.com/BiotechCH/status/1616501430478864384) 2023-01-20T18:22Z 15.9K followers, 18.5K engagements "Today at 3pm ET @JMaraganore joins @daphnezohar & @JSchimmer_E to talk #biotech getting back to the office value creation for shareholders $AMZN generic meds $JNJ earnings & the latest updates from $PLRX $MGTA $TGTX and more #BiotechHangout https://bit.ly/3XE2CoS https://bit.ly/3XE2CoS" [X Link](https://x.com/BiotechCH/status/1618963669685248001) 2023-01-27T13:26Z 15.9K followers, 25.3K engagements "#BiotechHangout today: @daphnezohar @JSchimmer_E @TheDawnBell @SamFazeli8 talk earnings big pharma revenue drivers & program cut implication on biotechs data FDA leadership changes Medicare RADV rule SV vs biotech innovation $AMGN Humira biosim +more https://x.com/i/spaces/1OwxWwrlgjjxQ https://x.com/i/spaces/1OwxWwrlgjjxQ" [X Link](https://x.com/BiotechCH/status/1621512516043145218) 2023-02-03T14:14Z 15.9K followers, 22.5K engagements "Todays #BiotechHangout: @daphnezohar @JSchimmer_E @TimOpler & @JMaraganore discuss pharma on the hunt for deals data earnings govt pressure on drug pricing & patents lackluster pharma returns & how these factors will impact the business of biotech https://x.com/i/spaces/1OwGWwrOdnRGQ https://x.com/i/spaces/1OwGWwrOdnRGQ" [X Link](https://x.com/BiotechCH/status/1624053569388158977) 2023-02-10T14:31Z 15.9K followers, [----] engagements "https://x.com/i/spaces/1PlJQpEjMbnGE https://x.com/i/spaces/1PlJQpEjMbnGE" [X Link](https://x.com/BiotechCH/status/1626672221736296455) 2023-02-17T19:57Z 15.9K followers, 27.3K engagements "Todays #BiotechHangout: @SamFazeli8 @daphnezohar @JSchimmer_E & @TimOpler discuss #Biden agenda pricing pressures & $SIVB bank run impact on $XBI $ADAP & $TCRR merger $BBIO data busy private financings week $LLY data & the need for FDA panel votes http://bit.ly/3ZUkNaK http://bit.ly/3ZUkNaK" [X Link](https://x.com/BiotechCH/status/1634191681930121218) 2023-03-10T13:57Z 15.9K followers, 10.2K engagements "#BiotechHangout today: @bradloncar @daphnezohar @JSchimmer_E @mpreminger @LifeSciVC @TimOpler talk #AACR2023 abstracts private & public funding & funds company setbacks & comebacks #FDA mifepristone #FTC data + more https://x.com/i/spaces/1MYGNgpmmwOJw https://x.com/i/spaces/1MYGNgpmmwOJw" [X Link](https://x.com/BiotechCH/status/1646854846262267906) 2023-04-14T12:36Z 15.9K followers, [----] engagements "On #BiotechHangout today is @BellusHealth CEO @rbellini to talk this week's deals & financings w/hosts @daphnezohar @bradloncar @TimOpler @SamFazeli8 & @TheDawnBell plus innovation strategies AACR recap domestic R&D amortization impact on biotech & more https://x.com/i/spaces/1mnxeRoMgQZKX https://x.com/i/spaces/1mnxeRoMgQZKX" [X Link](https://x.com/BiotechCH/status/1649391960094801920) 2023-04-21T12:37Z 15.9K followers, 12.7K engagements "CEO of @MorphicTx @Ptipirneni joins today's #BiotechHangout to talk this weeks data w/ hosts @daphnezohar @Timopler @JSchimmer_E @JMaraganore & @robperez32 plus Big Pharma pipeline adjustments & M&A messaging deals financings regulatory & more https://x.com/i/spaces/1MnGnpZNlXmxO https://x.com/i/spaces/1MnGnpZNlXmxO" [X Link](https://x.com/BiotechCH/status/1651920795894001664) 2023-04-28T12:06Z 15.9K followers, 11.3K engagements "On #BiotechHangout @daphnezohar @bradloncar @OtelloVC @LifeSciVC & @Seals310 will talk @FTC $HZNP/ $AMGN & impact on SMIDs $PFE/ $SGEN $AKRO & $CHRS offerings & $QURE royalty deal $ICPT $VKTX $PTCT & $XFOR data & $PRTA/Dunn https://x.com/i/spaces/1mnGeRvjevNJX https://x.com/i/spaces/1mnGeRvjevNJX" [X Link](https://x.com/BiotechCH/status/1659308239287205894) 2023-05-18T21:21Z 15.9K followers, 10.6K engagements "Join us today at our new time (12pm EDT) for #BiotechHangout @daphnezohar @TimOpler @JSchimmer_E @bradloncar & @cngarabedian talk deals including $AVIR $NVS/ $PHAR & $LZAGY/ Synnafix; regulatory developments for $AMLX ALS drug $ILMN; #ASCO2023 data from $PFE $SNY $ICVX $BHVN + last weeks news including $IRWD/ $VECT FDA $SRPT decision & DOJ on short selling https://twitter.com/i/spaces/1lDGLnrBlAbxm https://twitter.com/i/spaces/1lDGLnrBlAbxm" [X Link](https://x.com/BiotechCH/status/1664606565976907776) 2023-06-02T12:15Z 15.9K followers, 17.7K engagements "On June [--] @daphnezohar @bradloncar @JMaraganore & @ColonGraceE will host a special session of #BiotechHangout Live at #BIO2023 moderated by @DavidThomasCFA. They will talk H2 outlook for SMID cap biotechs capital formation issues & impact & other #biotech industry news. Check back next week for the replay & dont forget to join #BiotechHangout on June [--] @12pm ET http://bit.ly/45W7H0z http://bit.ly/45W7H0z" [X Link](https://x.com/BiotechCH/status/1665701267291635713) 2023-06-05T12:45Z 15.9K followers, 10.5K engagements "This morning at #BIO2023 @daphnezohar @bradloncar @JMaraganore @ColonGraceE & @DavidThomasCFA hosted a special live session of #BiotechHangout. They discussed hot topics from the conference H2 outlook for SMID cap biotechs capital formation issues & impact and the latest in #biotech industry news. Watch the replay below" [X Link](https://x.com/BiotechCH/status/1666546543912972288) 2023-06-07T20:43Z 15.9K followers, 26.7K engagements "On todays #BiotechHangout @daphnezohar @bradloncar @JSchimmer_E @JMaraganore & @OtelloVC talk #BIO2023 takeaways $MRK sues US govt $DAWN $IONS $NAMS $COGT $VXRT $BIIB $JAZZ & $PRTK deals/financings M&A plus $PDSB $IMGN $REPL $AUTL $FDMT Dizal & Bicara data & oncology response criteria https://twitter.com/i/spaces/1rmxPkAdvEQJN https://twitter.com/i/spaces/1rmxPkAdvEQJN" [X Link](https://x.com/BiotechCH/status/1667139584629637129) 2023-06-09T12:00Z 15.9K followers, 20.4K engagements "Tomorrow's #BiotechHangout includes people in the news as @JSchimmer_E @daphnezohar @TimOpler @bradloncar & @mpreminger talk Sarissa/ $ALKS $BIIB board. Also $KDNY/ $NVS $LLY/ $VERV short selling Turnstone Biologics Disc Medicine data: Laronde Intellia $TSVT $EDIT $KURA & $OCUL plus Ram Sasiekheran speaks out & what it should mean for accusers https://twitter.com/i/spaces/1YqKDoEnNyaxV https://twitter.com/i/spaces/1YqKDoEnNyaxV" [X Link](https://x.com/anyuser/status/1669453416559439874) 2023-06-15T21:14Z 15.9K followers, 11.5K engagements "On todays #BiotechHangout @bradloncar @cngarabedian @TimOpler & @TheDawnBell will discuss Leqembi FDA approval $ADCT trial $ILMN fine $VRDN data $APGE/ Sagimet IPO plans $ALPMY/ $FDMT deal Tenpoint Therapeutics Series A FDA imports cancer drugs $BGNE/ $NVS terminate agreement China licensing deals $AVRO $NVDA invests in $RXRX $NBTX/ $JNJ deal & more https://twitter.com/i/spaces/1MnxnppRYndGO https://twitter.com/i/spaces/1MnxnppRYndGO" [X Link](https://x.com/BiotechCH/status/1679845401573175298) 2023-07-14T13:28Z 15.9K followers, 12.2K engagements "Guest Neil Kumar $BBIO CEO joins @daphnezohar @TimOpler @bradloncar @LifeSciVC & @BrianSkorney on this weeks #BiotechHangout to discuss $BBIO positive Ph [--] ATTR-CM data. Plus $APLS $ARGX $ABOS $LLY AD data PRVs data integrity (including Tessier-Lavigne) & some deals & financings including $PFE/ @FlagshipPioneer deal https://twitter.com/i/spaces/1rmxPkkBdeVJN https://twitter.com/i/spaces/1rmxPkkBdeVJN" [X Link](https://x.com/BiotechCH/status/1682040197649960960) 2023-07-20T14:50Z 15.9K followers, 26K engagements "On #BiotechHangout tomorrow @daphnezohar @TimOpler @bradloncar @LifeSciVC @OtelloVC & @Seals310 will cover the weeks deals & financings incl $EQRX / $RVMD & Alexion acquiring $PFE rare disease gene therapy portfolio big week of Q2 earnings: $PFE $REGN $TGTX $IMGN $MRK $MRNA $VRTX $SDGR plus $BIIB & $SAGE PDUFA for Zuranolone $VRTX data SVB healthcare report & the biotech employment market https://twitter.com/i/spaces/1RDGlalkYOdJL https://twitter.com/i/spaces/1RDGlalkYOdJL" [X Link](https://x.com/BiotechCH/status/1687197875464220677) 2023-08-03T20:24Z 15.9K followers, [----] engagements "On #BiotechHangout today @bradloncar @cngarabedian @SamFazeli8 @robperez32 & @eperlste discuss the influence of GLP-1s in light of $NVO positive study results & $LLY rising revenue data & regulatory news from $NVS $SAGE $NKTR/ $LLY $MRTX & Iveric plus $BLU $BNTX & $MRNA Q2 earnings $REGN buys $DBTX and Nasdaq threatens to delist $TSHA https://twitter.com/i/spaces/1jMJgLmBZOXxL https://twitter.com/i/spaces/1jMJgLmBZOXxL" [X Link](https://x.com/BiotechCH/status/1689984617489543169) 2023-08-11T12:58Z 15.9K followers, 10.2K engagements "#BiotechHangout will be taking a break the next two weeks for the end of summer. Well be back after Labor Day on September 8th at 12pm ET" [X Link](https://x.com/BiotechCH/status/1694819728487748083) 2023-08-24T21:11Z 15.9K followers, [----] engagements "Were back #BiotechHangout @daphnezohar @TheDawnBell @cngarabedian @BrianSkorney & guest @Frank_S_David talk data VC & crossover market dynamics hub & spoke funding (Apollo Nimbus & Star TX) $AMGN & $HZNP Nestle sells peanut allergy treatment it acquired for $2B+ for undisclosed amount $GMAB/ $SGEN $CBAY & $TNXP data $APLT stock price increase $OLMA financing & the [--] drugs for Medicare price negotiations https://twitter.com/i/spaces/1vOxwMdBQVmGB https://twitter.com/i/spaces/1vOxwMdBQVmGB" [X Link](https://x.com/BiotechCH/status/1700128752531825039) 2023-09-08T12:47Z 15.9K followers, 19.3K engagements "#BiotechHangout hosts @daphnezohar @cngarabedian & @bradloncar spoke with @AlexWestchester during the @GENbio The State of Biotech event today where they discussed the latest in biotech business trends including market conditions #InflationReductionAct the impact of mental health and @BiotechTVHQ" [X Link](https://x.com/BiotechCH/status/1702064040158073108) 2023-09-13T20:57Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @daphnezohar @TimOpler @YaronWerber & @Seals310 + guest @gline talk $XBI sentiment $ICPT acquisition $ABBV/ $IMAB deal $GILD trial $APLS Favus report $IONS $MORF & $IMVT data $BHVN stock move on preclin data $BMS/ $AZN price negotiations + more https://twitter.com/i/spaces/1nAKEaOelnlKL https://twitter.com/i/spaces/1nAKEaOelnlKL" [X Link](https://x.com/BiotechCH/status/1707737778492989823) 2023-09-29T12:43Z 15.9K followers, 13.9K engagements "On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @LifeSciVC @TheDawnBell and @MatteisPaul cover #CTAD23 #WorldSleepCongress Bipartisan biopharma initiatives being advanced in Congress OrbiMed $4.3B fund & are big VC rounds back $ROIV/$RHHBY Telavant acquisition CARGO IPO $BMY acquires rights from $LIAN Alzheimers news $NVS filing pushed @BernieSanders NIH investigation + middlemen impacting cancer care https://twitter.com/i/spaces/1lPKqbNZzLYGb https://twitter.com/i/spaces/1lPKqbNZzLYGb" [X Link](https://x.com/BiotechCH/status/1717913266372976768) 2023-10-27T14:36Z 15.9K followers, 12.7K engagements "On todays #BiotechHangout @daphnezohar @gline @biotech1 @TimOpler @cngarabedian & @BrianSkorney discuss $SNY big drop + pharma stock performance $SRPT trial miss $LLY/ $BEAM agreement $CRSP/ $VRTX adcomm $PFE cost cuts $AMGN discontinues PSMA BiTE new investment funds (Abingworth $OWL Bioluminescence Ventures Sofinnova Partners) Lexeo $113M IPO $FDMT CF gene therapy $AZN $245M investment in $CLLS + more https://twitter.com/i/spaces/1dRJZEwjBAMGB https://twitter.com/i/spaces/1dRJZEwjBAMGB" [X Link](https://x.com/BiotechCH/status/1720430791174279570) 2023-11-03T13:20Z 15.9K followers, 13.7K engagements "On #BiotechHangout today @daphnezohar @TimOpler @biotech1 @cngarabedian @JMaraganore & @eperlste cover #JefferiesHealthcare + @Stifel Healthcare conf takeaways CAR-T data updates at #ACR23 $AJINY acquires Forge ($620M) $GILD/ Arcellx partnership $ALKS spins out $MURA mergers including: Lenz/ $GRPH Q32 Bio/ $FIXX + $SELB/ $RNAC plus $CRSP/ $VRTX MHRA approval $VERV Ph1b data $PRTC Ph2a data $NVO trial risk reduction $MRK P2XH inhibitor briefing docs Astellas/ Propella $175M acquisition + more https://twitter.com/i/spaces/1BRKjPDajaLJw https://twitter.com/i/web/status/1725520299486032022" [X Link](https://x.com/BiotechCH/status/1725520299486032022) 2023-11-17T14:24Z 15.9K followers, 15.4K engagements "On #BiotechHangout today @daphnezohar @bradloncar @JMaraganore @biotech1 @LifeSciVC & @YaronWerber cover $ABBV / $IMGN $10B acquisition FDAs CAR-T safety concerns data setbacks & wins ( $ROIV $ARGX $XENE & $IVMT) $REGN & $SNY seek to expand Dupixent approval to COPD $SWTX approval plus @JAMAInternalMed paper calls to eliminate orphan drug exemptions $SLRN & $BIVI point to CRO errors in trial failures X Prize $101M prize in aging + financings/biotech sentiment https://twitter.com/i/spaces/1vOxwjmLZeLJB https://twitter.com/i/spaces/1vOxwjmLZeLJB" [X Link](https://x.com/BiotechCH/status/1730588048071491981) 2023-12-01T14:01Z 15.9K followers, 18.5K engagements "Were excited to once again be hosting our #Tweetup #Xup #BiotechHangout event at #JPM24 thanks to our sponsors @JNJNews @PureTechH @FTIConsulting @PointCross_LS @BancofCal & @misprobiotech Meet us at Persona (same location as last year) on Tuesday January 9th from 7-10pm. RSVP now to be sure youre on the list https://bit.ly/47Tr370 https://bit.ly/47Tr370" [X Link](https://x.com/BiotechCH/status/1734953148387573949) 2023-12-13T15:07Z 15.9K followers, [----] engagements "Wishing everyone a safe and happy holiday season Biotech Hangout will return on January 5th. In the meantime we invite you to register for our #Tweetup #Xup #JPM24 event on January 9th - all made possible thanks to our sponsors @JNJNews @PureTechH @FTIConsulting @PointCross_LS @BancofCal & @misprobiotech https://bit.ly/47Tr370 https://bit.ly/47Tr370" [X Link](https://x.com/BiotechCH/status/1737830454575661510) 2023-12-21T13:40Z 15.9K followers, 29.9K engagements "Were just [--] week away from the #BiotechHangout #Tweetup #Xup event at #JPM24 We have some of the best of #BioTwitter attending. Hope to see you IRL on Tues Jan [--] at Persona Be sure to RSVP: https://bit.ly/47Tr370 https://bit.ly/47Tr370" [X Link](https://x.com/BiotechCH/status/1742268013041074283) 2024-01-02T19:33Z 15.9K followers, [----] engagements "Get ready for the #JPM24 scavenger hunt If you see these people anywhere in San Fran (including enroute on your flight) take a pic w/ them & tag us. Hint: many on the list might be found mingling at our #BiotechHangout #Tweetup #Xup so dont forget to RSVP. Winners will be announced at the event: http://bit.ly/47Tr370 http://bit.ly/47Tr370" [X Link](https://x.com/BiotechCH/status/1742982646911688953) 2024-01-04T18:53Z 15.9K followers, 10.9K engagements "#BiotechHangout is back this week w/ @daphnezohar @biotech1 @TimOpler @PeterKolchinsky @MatteisPaul & @luba_greenwood to catch up on the news including end of year M&A from $BMY/ $KRTX $BMY/ $RYZB & $AZN/ Gracell FDA approves $AZN/ $IONS treatment & puts $IOVA therapy on hold $LBPH & $DYN data $NVS/ $VYGR collab $GS life science investment $IBRX financing RA Capitals latest sector analysis + [----] outlook sentiment hot areas & big picture issues & debate https://twitter.com/i/spaces/1rmxPMVnnAdKN https://twitter.com/i/spaces/1rmxPMVnnAdKN" [X Link](https://x.com/BiotechCH/status/1743275884709134481) 2024-01-05T14:18Z 15.9K followers, 10.3K engagements "Our #Biotwitter friends filled the room at the #BiotechHangout #Tweetup #Xup tonight Our scavenger hunt is going strong with so many great photos captured so far. The winners will be announced later this week #JPM24" [X Link](https://x.com/BiotechCH/status/1744939036681044245) 2024-01-10T04:27Z 15.9K followers, [----] engagements "On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @SamFazeli8 & @TheDawnBell discuss #JPM24 takeaways deals: $MRK/ $HARP $JNJ/ $AMAM $GSK/ Aiolos $BSX/ $AXNX + $NVS deal spree ( $CYTK Calypso Biotech Shanghai Argo $LLY/Isomorphic) plus Metagenomi & ArriVent preclinical IPOs $KYMR offering $ALPMY CRL $VRTX pauses trial & more https://twitter.com/i/spaces/1ZkKzjQAEVoKv https://twitter.com/i/spaces/1ZkKzjQAEVoKv" [X Link](https://x.com/BiotechCH/status/1745810013380112403) 2024-01-12T14:08Z 15.9K followers, 13.9K engagements "Thanks again to everyone who attended our #BiotechHangout #Tweetup #Xup event & participated in the scavenger hunt. @US_FDA commissioner Rob Califf plus Rick Pierce & Peter Marschel from Decoy Therapeutics author @angelosgeo @MereoBioPharma CEO @ScotsKnight2 $EXAI's @drrichjlaw plus hosts @daphnezohar @bradloncar @biotech1 @JMaraganore & @eperlste amongst others were captured in photos as part of the hunt. Shoutout to @mpreminger @luba_greenwood @DeborahMoorad & @julie_norville for some great posts" [X Link](https://x.com/BiotechCH/status/1745921872569499739) 2024-01-12T21:33Z 15.9K followers, [----] engagements "On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @JMaraganore & @ColonGraceE cover $KYTX & other IPO filings eg $CGON Alto Neuroscience and digital biomarkers (FDA clears AI Alzheimers predictor & AI programs for diagnosing IPF) $BBIO secures capital from $OWL & Canada Pension Plan Investments FDA expands $VRTX & $CRSP's Cagevy $RGNX data Vivek Ramaswamy out of US pres. race Wiley Chambers retires plus early stage funding & what investors should do better https://twitter.com/i/spaces/1yoKMwmmwWDJQ https://twitter.com/i/spaces/1yoKMwmmwWDJQ" [X Link](https://x.com/BiotechCH/status/1748345032225050690) 2024-01-19T14:01Z 15.9K followers, [----] engagements "On todays #BiotechHangout @bradloncar @TimOpler @luba_greenwood & @BrianSkorney discuss $KURA $DNTH $ORIC & $OTLK private placements $CYTK $LLY & $IONS data PIPES/FOs $AMGN & other FDA black box warnings $SNY buys $INBX measles surge How CAR-T relates to metabolism $MRK/ $UNP collab $AVBP prices IPO $GILD Ph3 study FDA approves $JNJ's Balversa & finds manuf lapses at $LLY plus House Ways and Means Committee approves restoration of R&D tax credit https://twitter.com/i/spaces/1LyGBnZnebaGN https://twitter.com/i/spaces/1LyGBnZnebaGN" [X Link](https://x.com/BiotechCH/status/1750879740221673776) 2024-01-26T13:53Z 15.9K followers, 12K engagements "On todays #BiotechHangout @daphnezohar @biotech1 @TimOpler @cngarabedian & @ColonGraceE cover the IPO market including $AUTL $SANA $MLYS $TNYA & $KYTX s upsized IPO $NVS to acquire $MOR for $2.9B $GILD walks away from Tizona deal data from $LLY $AMGN $FDMT $JNJ & $VRTX plus $GILD & $LLY drug discontinuations Novo Holdings to acquire $CTLT in $16.5B deal @US_FDA AI for drug surveillance Scion Life Sciences launches w/$310M fund & more: https://twitter.com/i/spaces/1YqxoDZNLyBKv https://twitter.com/i/spaces/1YqxoDZNLyBKv" [X Link](https://x.com/BiotechCH/status/1755958710914986112) 2024-02-09T14:15Z 15.9K followers, [----] engagements "@EricSchmidt151 .@TimOpler talks about the financial raises from $CRSP and $SANA this week saying hats off to $SANA for being terrific engineers of allogeneic cells and innovating around removing the immune response to those cells. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1758546498055295400) 2024-02-16T17:38Z 15.9K followers, [---] engagements ".@daphnezohar notes that one thing we havent seen a lot of is companies winding down & returning capital to shareholders. This week we saw two cases 1) $MACKs plan to distribute the proceeds of this weeks $225M milestone payment from $IPSEY following FDA approval of their product to the companys shareholders and 2) LianBio announcing they are winding down and the board declared a special cash dividend of $528M or $4.80 per ordinary share. #BiotechHangout https://twitter.com/i/web/status/1758549394473750676 https://twitter.com/i/web/status/1758549394473750676" [X Link](https://x.com/BiotechCH/status/1758549394473750676) 2024-02-16T17:50Z 15.9K followers, [---] engagements "On todays #BiotechHangout @daphnezohar @bradloncar @biotech1 @EricSchmidt151 @YaronWerber discuss FDA news: $IOVA s Amtagvi approval fast track for $IONS & $AZN s eplontersen $SRPT s Elevidys label expansion review two $RAPT drug trials on hold $UTHR litigation & $ALNY s ATTR trial endpoint changes plus FTC challenges & new roadblocks for $ABBV $CERE $ABBV CEO retires IQVIAs global R&D trends report Bayer cuts dividend by 95% $REGN & $VRTX cross $100B market cap threshold @Stifel reports R&D stage pharma up 19.8% outperformance of secondary offerings & IPOs & more:" [X Link](https://x.com/BiotechCH/status/1761026132722286750) 2024-02-23T13:52Z 15.9K followers, [----] engagements "On todays #BiotechHangout @bradloncar @biotech1 @cngarabedian @ColonGraceE @EricSchmidt151 discuss data from $RHHBYs Ph3 Enspryng gMG trial & $CRNX Ph3 Paltusotine trial $AZN acq of $FUSN & the radiopharm space Mirador launch (former Prometheus team) & megarounds rare disease news: newly approved Lenmedlys $4.25M price tag creation of Orphan Therapeutics Accelerator & lobbying exceptions for orphan drugs plus this weeks executive order on womens health research BIOs position reversal on BioSecure Act and more: https://twitter.com/i/spaces/1OyJAWABYzNKb" [X Link](https://x.com/BiotechCH/status/1771160985086099621) 2024-03-22T13:04Z 15.9K followers, [----] engagements "On #BiotechHangout today @cngarabedian @biotech1 @TheDawnBell @MatteisPaul @YaronWerber discuss this weeks deals in the ADC space: $GMAB/Profound Bio $IPSEY/ $STRO & Merck/Caris more big private deals: Metsera Oruka Obsidian Alterome Neurosterix & Contineum also data from $ROIV $GRTS Verve LENZ & $VRTX plus Amylyx pulls ALS drug from market $ACOR & Eiger bankruptcies & more: https://twitter.com/i/spaces/1YqxoDmeAzzKv https://twitter.com/i/web/status/1776233725472247889 https://twitter.com/i/spaces/1YqxoDmeAzzKv https://twitter.com/i/web/status/1776233725472247889" [X Link](https://x.com/BiotechCH/status/1776233725472247889) 2024-04-05T13:01Z 15.9K followers, [----] engagements "@cngarabedian @biotech1 @TheDawnBell @MatteisPaul @YaronWerber @bradloncar @daphnezohar @LifeSciVC @SamFazeli8 @luba_greenwood @TimOpler @mpreminger @JMaraganore Kicking off a big week of private deals @TheDawnBell discusses Metsera coming out of stealth with $350M and how their GLP-1 pipeline is as robust or more robust than some of the other leaders in the anti-obesity space. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1776280638464704917) 2024-04-05T16:08Z 15.9K followers, [---] engagements "On todays #BiotechHangout @bradloncar @daphnezohar @luba_greenwood @EricSchmidt151 discuss inflation effects on biotech stocks more fallout from the BioSecure Act #AACR2024 $VRTX acquisition of $ALPN for $4.9B in cash $NVS pays $150M for $ARVNs prostate cancer therapy US govt lawsuit against $REGN LSE challenges w/ companies delisting and leaving @AAMortazavi joins us some big personnel moves $XBI and more https://twitter.com/i/spaces/1ynJOyVwPmzKR https://twitter.com/i/spaces/1ynJOyVwPmzKR" [X Link](https://x.com/anyuser/status/1778773600067019099) 2024-04-12T13:14Z 15.9K followers, 10.7K engagements "On todays #BiotechHangout @cngarabedian @biotech1 @TimOpler @JMaraganore share their perspectives on PIPES supply/demand of venture capital & @nytimes article on WuXi plus discuss $DNA & $ADAP end collab Future Pak to acquire $VNDA $SNY divests Amuniz & $REGN builds venture arm data: $RARE $BHVN $SAGE $LLY $RHHBY & $NVS also $CGEM expands into autoimmune diseases Baker Bros returns $10b to shareholders Humira biosimilar grabs market share & much more: https://twitter.com/i/spaces/1kvJpvWnargKE https://twitter.com/i/spaces/1kvJpvWnargKE" [X Link](https://x.com/BiotechCH/status/1781306457511661940) 2024-04-19T12:58Z 15.9K followers, 10.7K engagements "On todays #BiotechHangout @biotech1 @bradloncar @TimOpler @EricSchmidt151 @SamFazeli8 @JacobPlieth @ByMadeleineA cover #ASCO24 highlights shifting pharma oncology interests more data: $LLY $AGIO $ANNX $AMGN plus competitive dynamics: $GPCR vs the big leagues $BBIO / $BMRN $CRNX / $NBIX $VIR / $GILD Lykos ad comm Hengrui Form [---] II voting season the latest on Biosecure M&A sector/macro highlights & much more: https://twitter.com/i/spaces/1djGXNPErEjxZ https://twitter.com/i/spaces/1djGXNPErEjxZ" [X Link](https://x.com/BiotechCH/status/1799062706332565891) 2024-06-07T12:55Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @cngarabedian @bradloncar @TimOpler @TheDawnBell @JMaraganore @EricSchmidt151 dig into the obesity market w/ a look at @Stifels report & key findings $PFEs once daily oral GLP-1 report on patients discontinuing GLP-1 drugs in [--] yrs & GLP-1s for obesity-related cancers plus deals of the week: $LLY to acquire $MORF for $3.2B & Flagships $3.6B fund clinical readouts: $RHHBYs TIGIT study $QUREs Huntingtons data $IDYAs MAT2A data and @evaluatepharmas World Preview report & pharma forecast & more: https://twitter.com/i/spaces/1gqGvNkPlBRGB" [X Link](https://x.com/BiotechCH/status/1811747635935527206) 2024-07-12T13:01Z 15.9K followers, [----] engagements "https://x.com/i/spaces/1yoKMyveRERKQ https://x.com/i/spaces/1yoKMyveRERKQ" [X Link](https://x.com/BiotechCH/status/1814328630933078385) 2024-07-19T15:57Z 15.9K followers, [----] engagements "Lower the price and also upsize. Very odd $ARTV Any thoughts Allocation strategy probably also could have used more thought. https://www.globenewswire.com/news-release/2024/07/18/2915688/0/en/Artiva-Biotherapeutics-Announces-Pricing-of-Upsized-167-0-Million-Initial-Public-Offering.html AutoImmune Cell Therapy - what is it worth: all eyes on the $ARTV IPO today. Nothing like a little old fashioned price discovery to keep you entertained on a Friday. 🔘Kyverna Therapeutics: Their early clinical findings in multiple sclerosis (currently Phase 2) have shown https://t.co/KJeEuIvz8g" [X Link](https://x.com/BiotechCH/status/1814658564490703274) 2024-07-20T13:48Z 15.9K followers, [----] engagements "Were excited to announce well once again be hosting our #BiotechHangout meetup at #JPM25 at Persona on Tuesday January 14th from 7-10pm. Interested in sponsoring the event Email team@biotechhangout.com for details Limited sponsorship spots available. Stay tuned for registration info" [X Link](https://x.com/BiotechCH/status/1863941247057924523) 2024-12-03T13:39Z 15.9K followers, [----] engagements "On todays #BiotechHangout @cngarabedian @biotech1 (Josh Schimmer) @t_lorriman @SamFazeli8 & @ceesay_abe discuss recent deals: $PTCT/$NVS $OLMA/$NVS $PSTX/Roche data: $AMGNs Maritide $LLY/$NVO head-to-head trial Roches TIGIT Ph3 results plus $SNTI $CGON $NVCR/$ZLAB $JANX data & other oncology movers: $RVMD & $NVCR & more topics including executive security latest insights on Trump nominees CNS outlook & more: https://twitter.com/i/spaces/1vAGROWBAMaJl https://twitter.com/i/spaces/1vAGROWBAMaJl" [X Link](https://x.com/BiotechCH/status/1865032555604418817) 2024-12-06T13:56Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @Biotech1 (Josh Schimmer) @YaronWerber @BrianSkorney @t_lorriman @EricSchmidt151 cover macro news of the week: new FTC head & what it means for M&A biopharma not challenging RFK Jr BioSecure Act missing from Defense Bill Luigi Mangiones arrest plus #ASH24 highlights: CAR-T battle: $ACLX/GILD vs $LGND/$JNJ $AGIO & other SCD cell therapies updates Blenreps return BTK degraders ($BGNE $NRIX) plus other news: $RVNC/Crown deal big movers: $CMRX $CDAL $QURE & updates from $RLAY $TRML $KRYS $KROS & more: https://twitter.com/i/spaces/1mrxmMrMWdvxy" [X Link](https://x.com/BiotechCH/status/1867569051486089321) 2024-12-13T13:55Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @cngarabedian @bradloncar @SamFazeli8 @YaronWerber discuss the state of the market & recap EOY reports $XBI outlook #JPM25 preview $GLGP splits in [--] $PFE YE update & Part D Redesign changes Novo/Valo Health deal & more China deals bird flu death & impact on stocks have we reached peak obesity plus $STOK moves to Ph3 for Dravet $JSPR & $VIR data & much more: https://twitter.com/i/spaces/1djGXrldzpExZ https://twitter.com/i/spaces/1djGXrldzpExZ" [X Link](https://x.com/BiotechCH/status/1877715709309993206) 2025-01-10T13:54Z 15.9K followers, [----] engagements "We look forward to seeing everyone tonight at Persona (685 Sutter St) for the #BiotechHangout @BiotechTVHQ networking event Open bar begins at 7pm thanks to our sponsors @JNJNews @misprobiotech @FTIConsulting @hellocatalytic @PureTechH : Join us in person for the @BiotechCH @BiotechTVHQ hangout from 7:00 to 10:00. All are welcome to attend. Stop by https://t.co/k5jCi9l8F3 : Join us in person for the @BiotechCH @BiotechTVHQ hangout from 7:00 to 10:00. All are welcome to attend. Stop by https://t.co/k5jCi9l8F3" [X Link](https://x.com/BiotechCH/status/1879258906154946837) 2025-01-14T20:06Z 15.9K followers, 11.4K engagements "Hanging out with @bradloncar @daphnezohar @TimOpler and Josh Schimmer at the #biotechhangout #tweetup. Share some pictures & tag us and we will share" [X Link](https://x.com/BiotechCH/status/1879374075434536979) 2025-01-15T03:44Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @cngarabedian @TimOpler @SamFazeli8 @BrianSkorney @luba_greenwood discuss public market sentiment capital markets & the IPO backlog Trumps latest moves: NIH WHO FDA hiring freeze immigration impact AI in healthcare: Stargate AI $RXRX Agenetic AI plus cancer vaccines the deal market Biogen R&D cuts $NVOs amycretin obesity drug data recent Nature paper on GLP-1 drugs effects & more: https://twitter.com/i/spaces/1YqGovvoMQyKv https://twitter.com/i/spaces/1YqGovvoMQyKv" [X Link](https://x.com/BiotechCH/status/1882791303945081173) 2025-01-24T14:03Z 15.9K followers, [----] engagements "On todays #BiotechHangout hosts @bradloncar @EricSchmidt151 @t_lorriman @luba_greenwood @TimOpler are joined by @adamfeuerstein to discuss zombie biotechs & the news of the week: $BIIB / $STOK deal $SLDB DMD gene therapy data & fundraising dynamics $SWTX buyout rumors $BLUE acquisition $SEPN drops lead asset $FGEN China deal $BBIO Attruby launch Formycon earnings glp1 compounding $HIMS soars & why doesnt Novo sue for patent infringement plus a look at deal activity shifts in pharma priorities cash flow investing market mood 13f filings & fund returns & much more:" [X Link](https://x.com/BiotechCH/status/1892938265579110685) 2025-02-21T14:03Z 15.9K followers, 11.5K engagements "Why does anyone listen to Betaville They constantly put out false rumors. Likely leaked by the banks trying to push a deal through. Even a broken clock is right twice a day if only we had any m&a let alone 1/20 of what bettaville claims if only we had any m&a let alone 1/20 of what bettaville claims" [X Link](https://x.com/BiotechCH/status/1893290835745054906) 2025-02-22T13:24Z 15.9K followers, 21.1K engagements "On todays #BiotechHangout @daphnezohar @EricSchmidt151 @t_lorriman @BrianSkorney @YaronWerber discuss market/investor blues #TDCowen Conf takeaways deals ($JAZZ + $CMRX $ABBV + $GUBRAMerck KgaA + $SWTX) data ($PLRX halts Ph2b IPF study $BHVNs promising Ph1 results for BHV-1300 $BMY scraps G12D inhibitor from $MRTX deal) RFK Jr.s #measles response Senate hearings for NIH/FDA Conflicts of interest incl. $PFE Cavazzoni from last week) networking dos & donts etc: https://x.com/i/spaces/1rmGPylBleEJN/peek https://x.com/i/spaces/1rmGPylBleEJN/peek" [X Link](https://x.com/BiotechCH/status/1898011292444832183) 2025-03-07T14:02Z 15.9K followers, [----] engagements "On todays #BiotechHangout @EricSchmidt151 @SamFazeli8 @YaronWerber are joined by @IAmBiotechs John Crowley to discuss BIOs near-term priorities how biopharma is working w/the new administration & status of the FDA plus news of the week including obesity updates: $NVOs CagriSema data $ZEAL + Roche deal $VKTX manufacturing deal & other news: key $AMGN Uplizna data at #AAN2025 heats up space small cap oncology acquisition trends w/ Sun Pharma / $CKPT $BMY / $TSVT deals $SWTX/Merck KgaA - deal or no deal earnings recaps: $BNTX & & $LEGN & more: https://twitter.com/i/spaces/1lPKqMPYklYKb" [X Link](https://x.com/BiotechCH/status/1900534105894199438) 2025-03-14T13:06Z 15.9K followers, 11.1K engagements "Biopharma Funds Are in Sick Bay (performance data) https://www.institutionalinvestor.com/article/2ej1odwnbkz58mdfdgpvk/biopharma-funds-are-in-sick-bay https://www.institutionalinvestor.com/article/2ej1odwnbkz58mdfdgpvk/biopharma-funds-are-in-sick-bay" [X Link](https://x.com/BiotechCH/status/1904187548039000207) 2025-03-24T15:04Z 15.9K followers, 15.9K engagements "https://x.com/i/spaces/1MYxNwQwXvQKw https://x.com/i/spaces/1MYxNwQwXvQKw" [X Link](https://x.com/BiotechCH/status/1905650490198708676) 2025-03-28T15:57Z 15.9K followers, 25.4K engagements "On DCF @EricSchmidt151 thinks that valuation is a fools game. Its garbage in and garbage out. Its black and white - what matters is if the drug works or notWe should spend a lot less time as a community working out models that are fictitious and a lot more time doing due diligence on what's going to work. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1933573672125465029) 2025-06-13T17:14Z 15.9K followers, 20.4K engagements "#BiotechHangout is taking a break this week and will be back on Friday June [--]. Have a great weekend" [X Link](https://x.com/BiotechCH/status/1935684186821578979) 2025-06-19T13:00Z 15.9K followers, [----] engagements "On today's #BiotechHangout @cngarabedian @daphnezohar @SamFazeli8 @MatteisPaul @t_lorriman & @TimOpler discuss market sentiment #BIO2025 recap & BIOs top priorities FDA listening tour & Makary's potential role in $KALVs rejection request ACIP meeting recap new CDER head China healthcare & future U.S.-China relations #ADA25: $LLYs updates $NVO's Amycretin & CagriSema Regor's oral RGT-075 $MTSR $NVO/$HIMS cancellation & fallout plus other data news: $CDTX's antiviral biologic $CMPS Ph3 psilocybin readout $NKTR Ph2b in atopic dermatitis $SRPTs challenges $RVMD/$RPRX $2B flexible funding deal a" [X Link](https://x.com/BiotechCH/status/1938587937530159414) 2025-06-27T13:19Z 15.9K followers, 10.2K engagements "On today's #BiotechHangout @ericschmidt151 @bradloncar @TimOpler & @t_lorrimancoverM&A: $MRK/$VRNA $ABBV/Capstan &a nod to the Biotech Sisterhood biotech takeouts by the numbersis this a biotechM&A waveOutlook for 2H25pharmas $150B in LOE approachingplus macro news: TrumpsBig Beautiful Bill and the latesttariffheadlines $XBI response & MFN rumorsstocks have recovered fromApril downturnis the outlookclearAnd onFDAfront: a group discussion on theCRL disclosures$CAPR DMD rejection plus$KALV approval $PROKs big move obesity trendsreport& $LLYs dominance $RARE/$MREO setbacks plus $ABBV/Ichnos deal" [X Link](https://x.com/anyuser/status/1943657240860192928) 2025-07-11T13:02Z 15.9K followers, [----] engagements "Im an investment banker and Im working on more M&A right now than I ever have. Buyers are now shopping commercial and there's a very simple reason - you need revenue and you can buy revenue notes @TimOpler. With a growing pool of commercial-stage biotech companies the market remains competitive but with fewer bidders per deal keeping premiums modest. #BiotechHangout" [X Link](https://x.com/BiotechCH/status/1943711396488736933) 2025-07-11T16:38Z 15.9K followers, 33.7K engagements "On todays #BiotechHangout @daphnezohar @biotech1 (Josh Schimmer) @BrianSkorney @MatteisPaul @SamFazeli8 & @gline will cover: Trump's letters to [--] pharmas re US drug pricing/MFN Prasad out at CBER good or bad for biotech CEO listening session w/ Makary & Tidmarsh RFK's plans (vaccine liability exposure U.S. Preventive Services Task Force) tariffs the latest $SRPT drama & management/board dynamics $GSK/Hengrui & China deals impact on $XBI $BMY/Bain spinco $GLPG restructuring $ABBV $1B Gilgamesh rumors long the launch: $ALNY $ARGX $NBIX data: Roche Alzheimer's study $LLY abeta prevention study" [X Link](https://x.com/BiotechCH/status/1951266701640626340) 2025-08-01T13:00Z 15.9K followers, [----] engagements "On todays #BiotechHangout @ColonGraceE @JMaraganore @MatteisPaul @EricSchmidt151 &@LifeSciVC will cover policy: RFK Jr. cancels mRNA vaccine contractslatest on MFN & Trumps pharma tariffs warning could Prasad come back $SRRK manufacturing debate data: $PRAX epilepsy update $VRTX in pain $AGIOs data & stock rollercoaster $PFE 3rd GLP-1 discontinuation $LLYs orforglipron results big pharma shifts: $NVO trims pipeline Bayer layoffs an earnings recap: $BBIO TGTX & $MDGL $MDGL licensing deal w/ China plus $NVO/$RNA deal rumors $YMAB acquisition $BIIBs venturesteam royalty markets ($XOMA OrbiMed)" [X Link](https://x.com/BiotechCH/status/1953803981756510323) 2025-08-08T13:02Z 15.9K followers, 10.8K engagements "Mark your calendars #BiotechHangout & @BiotechTV are back again for our annual IRL networking event at #JPM26 Join us at Persona on Tuesday January 13thfrom 7-10pm for a chance to meet up with biotech friends. Interested in sponsoring the event Reach out toteam@biotechhangout.comfor more information. Additional registration information to come" [X Link](https://x.com/BiotechCH/status/1980623951031333059) 2025-10-21T13:15Z 15.9K followers, [----] engagements "On todays #BiotechHangout @soowannaway (Graig Suvannavejh) @MatteisPaul @BrianSkorney @YaronWerber @cngarabedian & special guest @adamfeuerstein will cover policy & regulatory news: George Tidmarsh resigns from FDA $SRPT ESSENCE trial results & ties to FDA decisions FDA deems $QUREs #HuntingtonsDisease data inadequate & read throughs to $STOK ahead of #DravetSyndrome filing & Dec. FDA meeting $BHVN CRL plus: Arena BioWorks shuts down $NVO/$PFE bidding war for $MTSR escalates $SLNO Q3 earnings data: $CNTA & $HRMY #narcolepsy data $TERN up 90% on #CML data & much more:" [X Link](https://x.com/BiotechCH/status/1986795894637756846) 2025-11-07T14:00Z 15.9K followers, 13.6K engagements "At #ASH25 $LLYs Jaypicra announced Ph3 data highlighting fierce competition in the BTK inhibitor space with $ONC & others. The data from $LLY is very early. In general it's supposed to be safer but the safety differences honestly ended up being a little marginal says @YaronWerber. Finally $ONC has a monster pipeline in CLL including a BCL2 inhibitor in combination and a BTK degrader. Frankly they've moved their BTK degrader now to be tested head-to-head against $LLYs drug. So this is going to be fireworks for a while. Bottom line is you could argue: $ONC is no longer the absolute leader." [X Link](https://x.com/BiotechCH/status/1999537347122036952) 2025-12-12T17:50Z 15.9K followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@BiotechCH Biotech HangoutBiotech Hangout posts on X about $lly, $amgn, ipo, $nvs the most. They currently have [------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.
Social category influence stocks 59.82% finance 25.89% cryptocurrencies 14.29% countries 8.04% currencies 6.25% technology brands 2.68% social networks 0.89% exchanges 0.89% vc firms 0.89% financial services 0.89%
Social topic influence $lly 10.71%, $amgn #89, ipo #849, $nvs 9.82%, sentiment #1167, ceo 8.04%, $vrtx 8.04%, china 7.14%, $azn 6.25%, $mrk 6.25%
Top accounts mentioned or mentioned by @daphnezohar @bradloncar @timopler @cngarabedian @samfazeli8 @ericschmidt151 @biotech1 @yaronwerber @jschimmere @jmaraganore @matteispaul @brianskorney @lifescivc @thedawnbell @colongracee @tlorriman @lubagreenwood @mpreminger @soowannaway @seals310
Top assets mentioned Eli Lilly and Company (LLY) Amgen, Inc. (AMGN) Novartis AG (NVS) Vertex Protocol (VRTX) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) Gilead Sciences, Inc. (GILD) Johnson & Johnson (JNJ) AbbVie Inc (ABBV) GSK plc (GSK) Bristol-Myers Squibb Co (BMY) Biogen Inc (BIIB) BridgeBio Pharma, Inc. Common Stock (BBIO) Synthetify (SNY) Sarepta Therapeutics, Inc. (SRPT) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Regeneron Pharmaceuticals Inc (REGN) Revolution Medicines, Inc. (RVMD) Janux Therapeutics, Inc. (JANX) Moderna Inc (MRNA) Immunogen Inc (IMGN) 4D Molecular Therapeutics Inc. (FDMT) Alkermes Inc. plc (ALKS) Crinetics Pharmaceuticals, Inc. (CRNX) Alnylam Pharmaceuticals, Inc. (ALNY) Seagen Inc (SGEN) Verve Therapeutics Inc. (VERV) Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Sage Therapeutics, Inc (SAGE) Roivant Sciences Ltd. Common Shares (ROIV) CRISPR Therapeutics AG (CRSP) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Hims & Hers Health, Inc. (HIMS) Pliant Therapeutics, Inc. (PLRX) TG Therapeutics, Inc. (TGTX) Viking Therapeutics, Inc (VKTX) PTC Therapeutics, Inc. (PTCT) Illumina, Inc. (ILMN) Jazz Pharmaceuticals, Inc. (JAZZ) Recursion Pharmaceuticals, Inc. (RXRX) Apellis Pharmaceuticals, Inc. Common Stock (APLS) Novo-Nordisk (NVO) Mirati Therapeutics, Inc. Common Stock (MRTX) Olema Pharmaceuticals, Inc. (OLMA)
Top posts by engagements in the last [--] hours
"$PFEs and $MTSR GLP-1 and $AMGNs investigational MariTide programs shared clinical data. Whats encouraging is that both are reaffirming each other's data says @YaronWerber. We actually think both the $AMGN program and potentially this program are going to look very viable. And the KOL feedback has really turned the corner from being a little confused upfront to being fairly interested and supportive. #BiotechHangout https://twitter.com/i/web/status/2019832188691157472 https://twitter.com/i/web/status/2019832188691157472"
X Link 2026-02-06T17:54Z 15.9K followers, [---] engagements
"Good morning to our 20k followers on Clubhouse Its exciting to see how the community in @joinClubhouse continues to grow. Hope to see you soon Android users"
X Link 2021-04-11T13:45Z 15.9K followers, [--] engagements
"We asked on our last show what is the track record of short sellers. Elliot Favus sent us his closed positions. Copied below with permission in multiple tweets. Shared without endorsement or comment"
X Link 2023-10-01T11:41Z 15.9K followers, 75.5K engagements
"On todays #BiotechHangout @cngarabedian @BrianSkorney and @SamFazeli8 will kick off with general market sentiment & green shoots for biotech plus public & VC markets deals/financings: $ALKS/$AVDL $2.1B deal for #narcolepsy drug $SMMTs $500M raise w/ 50% insiders $ANRO & $NRIX financings $TAK-Innovent $1.2B upfront cancer drug deal #ESMO2025 recap: Tubulis data + $361M Series C $SMMT/Akeso Exelixis $INCY $JNJ impact on $MRUS/$GMAB/$BCAX/$CRBP TIGIT updates ($RCUS+ $AZN) & more highlights plus other data news & stock reactions: $ALEC/$GSK #dementia drug $VTYX cardio data $ARCT cystic fibrosis"
X Link 2025-10-24T13:00Z 15.9K followers, 10.1K engagements
".@YaronWerber dives into the $GILD and $ACLX data coming out of #ASH with anito-cel emerging as a potential best-in-class BCMA CAR-T for relapsed/refractory multiple myeloma: $JNJ and $LEGN have been the leaders for BCMA in myeloma. Their efficacy has been absolutely tremendousbut they do have some noticeable toxicity and it causes low rates of Parkinsonism The drug from $GILD $ACLX does not cause any of this toxicityWhen anito-cel comes to market next year because it's safer and it doesn't have any of these issues it's really going to be probably the preferred drug. It's really going to have"
X Link 2025-12-12T18:07Z 15.9K followers, [---] engagements
"On todays #BiotechHangout @SamFazeli8 @MatteisPaul @BrianSkorney & @t_lorriman will covermarket sentiment: $XBIs wobbly start& rebound on M&A news ahead of #JPM26politics:pediatric vaccine updates deals:M&A fundraisings & the firstIPOfiling to open the window $AZN/Jacobio deal $ABBV & $RVMD rumors plus data: $CRNX Palsonify launch & CAH clinical study $ZBIOtopline data for IgG4related disease $RAREs setrusumab update obesity news ($NVOs oral pill & $ARWR RNAi-based drug) $SNYs tolebrutinib CRL & pipeline outlook $NMRAsreadouts & $GHRSclinical hold lifted & preps for Ph3 $ALMS Ph3 psoriasis"
X Link 2026-01-09T14:00Z 15.9K followers, [----] engagements
".@MatteisPaul weighs in on $NMRAs oral Alzheimers agitation drug NMRA-511 that has shown some success in Phase 1b reducing agitation without sedation: The study showed a small trend for their drug versus placebo on an agitation scale. Alzheimer's agitation is a huge medical need that is super tough to treat. Really hard to have a drug that can help patients feel less agitated but also thread the needle on side effects like somnolence and sedationI would say from being someone who's followed a lot of these psychiatry readouts over the years and has gotten excited about things that look"
X Link 2026-01-09T18:15Z 15.9K followers, [---] engagements
"Big deal news: $GSK is paying $2.2B to acquire $RAPT betting on its Phase [--] anti-IgE antibody ozureprubart as a next-gen food allergy contender vs. Xolair. Its very strategic for $GSK as they have quite a nice presence in the immunology spacea very good deal to keep the M&A train going for biotech says @soowannaway. "That asset is coming from China in a transaction that consummated in Dec. '24 and $RAPT paid only $35M upfront for this asset. So great turn of events for this company. They've not done anything with this asset since in licensing it a little over a year ago. The Chinese company"
X Link 2026-01-23T17:50Z 15.9K followers, [---] engagements
"Another notable oncology deal: $JANX struck a collaboration and exclusive worldwide license with $BMY to develop a tumor-activated therapy for solid tumors. $JANX is a really interesting companythe stock has come down a lot on some disappointment around some of their lead programs. I do think the $BMY deal this week is a big vote of confidence in the platform says @TimOpler. #BiotechHangout https://twitter.com/i/web/status/2014759109396947041 https://twitter.com/i/web/status/2014759109396947041"
X Link 2026-01-23T17:56Z 15.9K followers, [---] engagements
"The area that $JANX plays in is masked bispecific antibodies for oncology says @EricSchmidt151. There are a couple other firms in the space too that are developing the ability to have these masked antibodies. They're only activated within the tumor microenvironment. So the idea here is that you can bring the benefit of an efficacious T cell-directed therapy to a cancer antigen without having the negativity of engaging those T cells outside of the tumor mass and triggering cytokine release syndrome or other inflammatory mechanisms. It's a foundational and fundamentally interesting tool. Again"
X Link 2026-01-23T17:57Z 15.9K followers, [---] engagements
"On this weeks #BiotechHangout @biotech1 (Josh Schimmer) @SamFazeli8 @BrianSkorney @YaronWerber are joined by @IAmBiotechs John Crowley to discuss latest perspectives on happenings&tone in D.C.: whats next with MFN FDA updates biotech race w/China($AZN $15B mfg. investment in China & $1.2B upfront deal w/CSPC) latest IRA list plusmarket sentiment:growing number of high-quality private companies & potential IPO feeding frenzy$IBB hittingnewhighswhile$XBIlags investor sentiment survey Eikon ($EIKN)IPO filing deals & investments: $MRK ends $RVMD dealtalks $RGNX clinical hold $MRNAs upcoming"
X Link 2026-01-30T14:00Z 15.9K followers, 10.5K engagements
"$MRK is no longer in discussions to buy $RVMD after failure to agree on price. The interesting part is that $RVMD doesn't need it. They've got great assets great data set coming out says @SamFazeli8. They've got data coming this year that could potentially change the landscape in pancreatic cancer and they have plenty of cash. They have just done a deal with Royalty Pharma and more money is available to them if they need to draw downSo it's probably a company that will eventually be attractive to a pharma company at some point. #BiotechHangout"
X Link 2026-01-30T17:55Z 15.9K followers, [---] engagements
"$AMGN resists an FDA request to pull Tavneos. The agency has flagged data from a [----] $CCXI trial: This drug has a long historyThe data were always kind of mixed. It looked like there was some activity there but through even Phase [--] and then Phase [--] studies the drug never quite was able to achieve I'd say a clearly positive result says @EricSchmidt151. #BiotechHangout https://twitter.com/i/web/status/2019827407415357762 https://twitter.com/i/web/status/2019827407415357762"
X Link 2026-02-06T17:35Z 15.9K followers, [---] engagements
"The FDA has signaled that it will go after mass compounders such as $HIMS. Good for Dr. Makary. If you look up what compounding pharmacies are supposed to be doing this is the exact opposite says @EricSchmidt151. They're supposed to be filling unmet medical niches right Taking drugs that are out there at different strengths or formulations and adjusting them to fit patients' needs where there are no commercializable therapiesHims and Hers is using their status as a compounding pharmacy to try and essentially get in the back door and rip off someone's IP. So I applaud the FDA for standing tall"
X Link 2026-02-06T17:50Z 15.9K followers, [---] engagements
"Fun fact: this year marks [---] years since the discovery of insulin Identified in [----] insulin was first used to treat Type [--] Diabetes in January [----]. Thank you to Felicia Pagliuca for setting the stage to talk about @VertexPharmas T1D research"
X Link 2021-10-24T20:41Z 15.9K followers, [--] engagements
"On todays #BiotechHangout @cngarabedian @Seals310 (Mike Yee) @MatteisPaul and @SamFazeli8 willrecap #JPM26 & market sentiment: [----] kickoffandM&Aandfinancing vibe this year state of VC investingcompany updates: $ALNY [----] updates & stock reactions $MRNA news & price auction deals: $ABBVs $650M PD1/VEGF deal w/ China AI partnerships regulatory: FDA guidance on cell & gene therapies plus $ATRAs CRL FDA CNPV voucher updates obesity: $LLY awaits FDA approval $AMGNs data & controversy big pharmaobesity hunt($ABBV & $BMY) other data: $LXEO PKP2 results $BMRN DMD exon skipping data & no safety"
X Link 2026-01-16T14:34Z 15.9K followers, [----] engagements
"$ALNY has unveiled their Alnylam [----] strategy where they lay out plans to scale global TTR leadership invest in transformative RNAi therapies and target $4.9-$5.3B in [----] revenues: We thought that maybe this [----] guide is not as much of a reach as others think said @MatteisPaul. We still felt like the update here from a fundamental perspective is still overall positive as it relates to the TTR franchise and the fact that they're going to be spending 30% of revenues on R&D. So you have to believe with four INDs a year they're going to get more meaningful drugs coming out of this companyI"
X Link 2026-01-16T17:37Z 15.9K followers, [---] engagements
"On todays #BiotechHangout @soowannaway (Graig Suvannavejh) @cngarabedian @EricSchmidt151 & @YaronWerber will cover market sentiment &IPO reception this week ($MANE $EIKN Generate Bios S-1 filing) $AMGNs refusal to pull rare disease drug at FDAs requestpolicy: rare PRV reauthorizationto [----] $CMPS psychedelic FDA PRV / WH rejection @NEJM article on Medicare drug pricing negotiations $AQST stock trading up on CRL obesity news: $HIMS launch of semaglutide pill & FDA response$PFE/$MTSR data plusothercompany news: $GSK returning rights to $WAVE for rare disease drug $UPBs upcoming Ph2 asthma data"
X Link 2026-02-06T14:03Z 15.9K followers, [----] engagements
"https://x.com/i/spaces/1lDGLBlpqMaxm https://x.com/i/spaces/1lDGLBlpqMaxm"
X Link 2026-02-06T16:58Z 15.9K followers, [----] engagements
"Kicking off todays show the hosts dive into a big week for IPOs headlined by $MANE and $EIKN: It looks like we are going to see a pretty healthy year with maybe six or seven IPOs priced in the first six weeks of the year says @EricSchmidt151. We're inundated with interest from private companies looking to potentially test this window. So as we've talked about before this could be a very very robust year in terms of numbers. #BiotechHangout https://twitter.com/i/web/status/2019821866139914312 https://twitter.com/i/web/status/2019821866139914312"
X Link 2026-02-06T17:13Z 15.9K followers, [---] engagements
"Flagship-backed Generate Biomedicines has filed for an IPO based on an AI and in silico antibody engineering platform. They're partnered with Amgen. They're partnered with Novartis. They have really impressive capabilities in labs says @YaronWerber. This is going to be a high quality one. Of course these are going to be areas with a lot of competitors. So that's the one thing to watch. #BiotechHangout https://twitter.com/i/web/status/2019825700971205000 https://twitter.com/i/web/status/2019825700971205000"
X Link 2026-02-06T17:29Z 15.9K followers, [---] engagements
"On today's #BiotechHangout @ColonGraceE @cngarabedian @SamFazeli8 @MatteisPaul @YaronWerber and special guest @johnbstanford will cover policy: NDAA provisions & implications for biotech industry trends & deals:big Monday w/ $1.85B inbiotech financings most in one day $XBIs sustained momentum & positive signals $LLYs acquisitive strategyplusFosun+$PFEdealfor oral GLP-1 conferences: #ASH2025 ($AZN $LLY vs $ONC$JNJ/$LEGN vs $GILD/ACLX $GMAB $TERN) #ESMOAsia25 ($BNTX Zelgen $GSK &otherADCs) $CGON at #SUO25 plus other data: $DYN positive DMD data obesity news ($GPCR $WVE Ascletis) Endpoints 100"
X Link 2025-12-12T14:36Z 15.9K followers, 10.9K engagements
"On todays #BiotechHangout @ColonGraceE @TimOpler @soowannaway (Graig Suvannavejh) & @EricSchmidt151 will cover market sentiment: [----] biopharma market outlook a bull/bear debate on the sector companies gearing up for IPOs are we ready deals: $GSKs $2.2B acquisition of $RAPT $JANX / $BMY $850M deal policy: US exits the WHO latest biotech funding bill topics FDAs MRD-negative guidelines for myeloma company news: $CRVS Ph1 atopic dermatitis data (stock jump & competitive landscape) plus @TimOplers womens health report & much more: https://twitter.com/i/spaces/1PlJQOplrNZKE"
X Link 2026-01-23T15:05Z 15.9K followers, [----] engagements
"$GSK returns rights to $WAVEs lead rare disease candidate WVE-006 for alpha-1 antitrypsin deficiency. What's interesting about this is that the reason was given that this might be too small of a market for $GSK but this is one of the larger rare diseases says @cngarabedian. Now having said that there's a new CEO that came into $GSK taking over from Emma Walmsley so that there's always those changes that come with a new CEOSo again it's just an interesting thing to watch for. Where is pharma prioritizing or not prioritizing Because investors need to understand who the natural acquirers for"
X Link 2026-02-06T18:06Z 15.9K followers, [---] engagements
"On todays #BiotechHangout @cngarabedian @t_lorriman @EricSchmidt151 @SamFazeli8 & @bradloncar cover deals/financing: $LBRX IPO (first since Feb) $TRML acquisition policy: the latest in China biotech: Washingtons response deals under scrutiny & stakeholder pushback plus the Trump administrations attack on direct-to-consumer marketing $RNA data + secondary offering #WCLC25: big share price moves & data from $SMMT $RVMD & $TIL $RVMD 1L PDAC $DNTH positive gMG data regulatory: FDA pulls $ICPTs liver drug Capsida gene therapy death FAERS report & impact on $SLNO SEC vs. $FGEN CMO $CAPRs letter to"
X Link 2025-09-12T13:01Z 15.9K followers, 15.2K engagements
"#BiotechHangout is taking a break this week for Presidents Day weekend & will return on Friday Feb. [--] at 12pm ET. While were away stream the latest episodes on Spotify Apple Podcasts Amazon Music YouTube & We hope you enjoy the long weekend with friends & family http://BiotechHangout.com http://BiotechHangout.com"
X Link 2026-02-12T12:05Z 15.9K followers, [---] engagements
"On Friday's #BiotechHangout @robperez32 joins @DaphneZohar & @JSchimmer_E to discuss the week's deals data & FDA actions w/ guests @AlexHarding7 & DiCE CEO @KevinJudice. Tell us if there's a topic you'd like us to cover below & tune in at 3pm ET https://x.com/i/spaces/1MYGNgRqRVvJws=20 https://x.com/i/spaces/1MYGNgRqRVvJws=20"
X Link 2022-10-20T13:37Z 15.9K followers, [--] engagements
"Tune in for #BiotechHangout this Friday at 3pm ET when @LifeSciVC @TimOpler & @DaphneZohar will cover the week in biotech & special guest Michael Yee will discuss why BAMG is the new FAANG & how generalists are now favoring big #biotech/#pharma https://x.com/i/spaces/1OwxWwggabRxQs=20 https://x.com/i/spaces/1OwxWwggabRxQs=20"
X Link 2022-11-03T13:12Z 15.9K followers, [--] engagements
"Today's #biotechhangout w/ @SamFazeli8 & @TheDawnBell. #Biotech priorities (patients/investors/incentives) single product cos ( $OYST & $ACOR) $EQRX pricing model $BIIB $SGEN CEOs $GSK $MACK #oncology & what endpoints matter $VERV $CLVS $ARWR + @LifeSciVC YE review"
X Link 2022-11-11T16:42Z 15.9K followers, [--] engagements
"Today @LifeSciVC @jmaxlevin @eperlste join @DaphneZohar/@JSchimmer_E to chat #Jefferies22 @a16z's "Biggest Company" deals/financings: $ACRV $NTRA $OPNT/ $INDV $LNTH/ $POINT FDA/clinical updates: $IMGN $PRVB $EDIT $ARDX perspectives on CEOs & politics etc #BiotechHangout"
X Link 2022-11-18T17:35Z 15.9K followers, [--] engagements
"We're back this Friday with @mpreminger @daphnezohar and @JSchimmer_E. @JacobPlieth will join as a special guest to talk all things #CTAD22 #oncology (#ASH22 $AZN $GSK) and more. Don't miss it #BiotechHangout"
X Link 2022-11-30T17:15Z 15.9K followers, [--] engagements
"Busy #BiotechHangout today @JebKeiper joins to discuss his $6B $TAK deal. @JSchimmer_E @daphnezohar @cngarabedian @timopler will talk M&A deals/financings ( $HZNP/ $AMGN $THRD $SIOX $ORTX) data (#ASH22 $ACET $AFMD $FATE $ALLO $CRBU $MRNA/ $MRK) & FDA w/ @RealEndptsMel"
X Link 2022-12-16T16:40Z 15.9K followers, 11.1K engagements
"Our #tweetup event #JPM23 is open to everyone in #biotech community. We recall embarrassing early career snubs from crashing closed JPM events (one of us was shamed by the CEO of a PR firm at her famous party). Reply w/your own story & we'll commiserate & share the best ones 🗣 Hey everyone the #Tweetup is moving to Tuesday this #JPM23. Its for everybody and we hope to see you there. Thanks to our sponsors @PureTechh @BankPacWest @misprobiotech @FTIConsulting @CoulterPartners Emerald Bioventures @MassBio RSVP here: https://t.co/YhMRsIlwRu https://t.co/TdJhCXXLCg 🗣 Hey everyone the #Tweetup"
X Link 2023-01-03T17:32Z 15.9K followers, 23.2K engagements
"We hope to see you next Tuesday at our #JPM23 #BiotechHangout #tweetup. Then @bradloncar & @cngarabedian will join us Friday 1/13 to recap RSVP: https://bit.ly/3FPAIyq https://bit.ly/3FPAIyq"
X Link 2023-01-06T21:12Z 15.9K followers, [----] engagements
"#JPM23 scavenger hunt. If you see these people anywhere in San Fran (or en route) take a pic w/ them & tag us. Win bragging rights & gift cards. Winners announced Tuesday night at the #tweetup. Rules here:"
X Link 2023-01-08T14:09Z 15.9K followers, 65.1K engagements
"Great turnout at the #tweetup #jpm23"
X Link 2023-01-11T03:41Z 15.9K followers, 11.5K engagements
"Congrats to our #BiotechHangout #JPM23 Scavenger Hunt winner @ashokamadduri who knocked it out of the park w/ @VasNarasimhan @DrCaliff_FDA @rickberke @ldtimmerman @bradloncar + more Honorable mentions go to @TheDawnBell & @mpreminger who didnt do too shabby either"
X Link 2023-01-11T18:32Z 15.9K followers, [----] engagements
"Thank you to everyone that made it out to the #BiotechHangout #Tweetup event in San Francisco last night It was wonderful to see so many friends from the #biotech community. #JPM23"
X Link 2023-01-11T19:52Z 15.9K followers, 10.7K engagements
"We talk #JPM23 news & sentiment w/ @DaphneZohar @JSchimmer_E @BradLoncar @ChrisGarabedian today: deals/financings #biotech stock performance [--] cos. pre-announce Q4 results (new trend) data FDA requires less animal work & halts more human trials + Brad TV #BiotechHangout"
X Link 2023-01-13T17:49Z 15.9K followers, 20.6K engagements
"Fidelitys Rajiv Kaul @LifeSciVC @TheDawnBell & @TimOpler join @daphnezohar at 3pm ET today to discuss industry sentiment & their approaches to assessing ideas. Will also cover deals financings data & FDA news. #BiotechHangout https://x.com/i/spaces/1dRKZMqEovXxBs=20 https://x.com/i/spaces/1dRKZMqEovXxBs=20"
X Link 2023-01-20T18:22Z 15.9K followers, 18.5K engagements
"Today at 3pm ET @JMaraganore joins @daphnezohar & @JSchimmer_E to talk #biotech getting back to the office value creation for shareholders $AMZN generic meds $JNJ earnings & the latest updates from $PLRX $MGTA $TGTX and more #BiotechHangout https://bit.ly/3XE2CoS https://bit.ly/3XE2CoS"
X Link 2023-01-27T13:26Z 15.9K followers, 25.3K engagements
"#BiotechHangout today: @daphnezohar @JSchimmer_E @TheDawnBell @SamFazeli8 talk earnings big pharma revenue drivers & program cut implication on biotechs data FDA leadership changes Medicare RADV rule SV vs biotech innovation $AMGN Humira biosim +more https://x.com/i/spaces/1OwxWwrlgjjxQ https://x.com/i/spaces/1OwxWwrlgjjxQ"
X Link 2023-02-03T14:14Z 15.9K followers, 22.5K engagements
"Todays #BiotechHangout: @daphnezohar @JSchimmer_E @TimOpler & @JMaraganore discuss pharma on the hunt for deals data earnings govt pressure on drug pricing & patents lackluster pharma returns & how these factors will impact the business of biotech https://x.com/i/spaces/1OwGWwrOdnRGQ https://x.com/i/spaces/1OwGWwrOdnRGQ"
X Link 2023-02-10T14:31Z 15.9K followers, [----] engagements
"https://x.com/i/spaces/1PlJQpEjMbnGE https://x.com/i/spaces/1PlJQpEjMbnGE"
X Link 2023-02-17T19:57Z 15.9K followers, 27.3K engagements
"Todays #BiotechHangout: @SamFazeli8 @daphnezohar @JSchimmer_E & @TimOpler discuss #Biden agenda pricing pressures & $SIVB bank run impact on $XBI $ADAP & $TCRR merger $BBIO data busy private financings week $LLY data & the need for FDA panel votes http://bit.ly/3ZUkNaK http://bit.ly/3ZUkNaK"
X Link 2023-03-10T13:57Z 15.9K followers, 10.2K engagements
"#BiotechHangout today: @bradloncar @daphnezohar @JSchimmer_E @mpreminger @LifeSciVC @TimOpler talk #AACR2023 abstracts private & public funding & funds company setbacks & comebacks #FDA mifepristone #FTC data + more https://x.com/i/spaces/1MYGNgpmmwOJw https://x.com/i/spaces/1MYGNgpmmwOJw"
X Link 2023-04-14T12:36Z 15.9K followers, [----] engagements
"On #BiotechHangout today is @BellusHealth CEO @rbellini to talk this week's deals & financings w/hosts @daphnezohar @bradloncar @TimOpler @SamFazeli8 & @TheDawnBell plus innovation strategies AACR recap domestic R&D amortization impact on biotech & more https://x.com/i/spaces/1mnxeRoMgQZKX https://x.com/i/spaces/1mnxeRoMgQZKX"
X Link 2023-04-21T12:37Z 15.9K followers, 12.7K engagements
"CEO of @MorphicTx @Ptipirneni joins today's #BiotechHangout to talk this weeks data w/ hosts @daphnezohar @Timopler @JSchimmer_E @JMaraganore & @robperez32 plus Big Pharma pipeline adjustments & M&A messaging deals financings regulatory & more https://x.com/i/spaces/1MnGnpZNlXmxO https://x.com/i/spaces/1MnGnpZNlXmxO"
X Link 2023-04-28T12:06Z 15.9K followers, 11.3K engagements
"On #BiotechHangout @daphnezohar @bradloncar @OtelloVC @LifeSciVC & @Seals310 will talk @FTC $HZNP/ $AMGN & impact on SMIDs $PFE/ $SGEN $AKRO & $CHRS offerings & $QURE royalty deal $ICPT $VKTX $PTCT & $XFOR data & $PRTA/Dunn https://x.com/i/spaces/1mnGeRvjevNJX https://x.com/i/spaces/1mnGeRvjevNJX"
X Link 2023-05-18T21:21Z 15.9K followers, 10.6K engagements
"Join us today at our new time (12pm EDT) for #BiotechHangout @daphnezohar @TimOpler @JSchimmer_E @bradloncar & @cngarabedian talk deals including $AVIR $NVS/ $PHAR & $LZAGY/ Synnafix; regulatory developments for $AMLX ALS drug $ILMN; #ASCO2023 data from $PFE $SNY $ICVX $BHVN + last weeks news including $IRWD/ $VECT FDA $SRPT decision & DOJ on short selling https://twitter.com/i/spaces/1lDGLnrBlAbxm https://twitter.com/i/spaces/1lDGLnrBlAbxm"
X Link 2023-06-02T12:15Z 15.9K followers, 17.7K engagements
"On June [--] @daphnezohar @bradloncar @JMaraganore & @ColonGraceE will host a special session of #BiotechHangout Live at #BIO2023 moderated by @DavidThomasCFA. They will talk H2 outlook for SMID cap biotechs capital formation issues & impact & other #biotech industry news. Check back next week for the replay & dont forget to join #BiotechHangout on June [--] @12pm ET http://bit.ly/45W7H0z http://bit.ly/45W7H0z"
X Link 2023-06-05T12:45Z 15.9K followers, 10.5K engagements
"This morning at #BIO2023 @daphnezohar @bradloncar @JMaraganore @ColonGraceE & @DavidThomasCFA hosted a special live session of #BiotechHangout. They discussed hot topics from the conference H2 outlook for SMID cap biotechs capital formation issues & impact and the latest in #biotech industry news. Watch the replay below"
X Link 2023-06-07T20:43Z 15.9K followers, 26.7K engagements
"On todays #BiotechHangout @daphnezohar @bradloncar @JSchimmer_E @JMaraganore & @OtelloVC talk #BIO2023 takeaways $MRK sues US govt $DAWN $IONS $NAMS $COGT $VXRT $BIIB $JAZZ & $PRTK deals/financings M&A plus $PDSB $IMGN $REPL $AUTL $FDMT Dizal & Bicara data & oncology response criteria https://twitter.com/i/spaces/1rmxPkAdvEQJN https://twitter.com/i/spaces/1rmxPkAdvEQJN"
X Link 2023-06-09T12:00Z 15.9K followers, 20.4K engagements
"Tomorrow's #BiotechHangout includes people in the news as @JSchimmer_E @daphnezohar @TimOpler @bradloncar & @mpreminger talk Sarissa/ $ALKS $BIIB board. Also $KDNY/ $NVS $LLY/ $VERV short selling Turnstone Biologics Disc Medicine data: Laronde Intellia $TSVT $EDIT $KURA & $OCUL plus Ram Sasiekheran speaks out & what it should mean for accusers https://twitter.com/i/spaces/1YqKDoEnNyaxV https://twitter.com/i/spaces/1YqKDoEnNyaxV"
X Link 2023-06-15T21:14Z 15.9K followers, 11.5K engagements
"On todays #BiotechHangout @bradloncar @cngarabedian @TimOpler & @TheDawnBell will discuss Leqembi FDA approval $ADCT trial $ILMN fine $VRDN data $APGE/ Sagimet IPO plans $ALPMY/ $FDMT deal Tenpoint Therapeutics Series A FDA imports cancer drugs $BGNE/ $NVS terminate agreement China licensing deals $AVRO $NVDA invests in $RXRX $NBTX/ $JNJ deal & more https://twitter.com/i/spaces/1MnxnppRYndGO https://twitter.com/i/spaces/1MnxnppRYndGO"
X Link 2023-07-14T13:28Z 15.9K followers, 12.2K engagements
"Guest Neil Kumar $BBIO CEO joins @daphnezohar @TimOpler @bradloncar @LifeSciVC & @BrianSkorney on this weeks #BiotechHangout to discuss $BBIO positive Ph [--] ATTR-CM data. Plus $APLS $ARGX $ABOS $LLY AD data PRVs data integrity (including Tessier-Lavigne) & some deals & financings including $PFE/ @FlagshipPioneer deal https://twitter.com/i/spaces/1rmxPkkBdeVJN https://twitter.com/i/spaces/1rmxPkkBdeVJN"
X Link 2023-07-20T14:50Z 15.9K followers, 26K engagements
"On #BiotechHangout tomorrow @daphnezohar @TimOpler @bradloncar @LifeSciVC @OtelloVC & @Seals310 will cover the weeks deals & financings incl $EQRX / $RVMD & Alexion acquiring $PFE rare disease gene therapy portfolio big week of Q2 earnings: $PFE $REGN $TGTX $IMGN $MRK $MRNA $VRTX $SDGR plus $BIIB & $SAGE PDUFA for Zuranolone $VRTX data SVB healthcare report & the biotech employment market https://twitter.com/i/spaces/1RDGlalkYOdJL https://twitter.com/i/spaces/1RDGlalkYOdJL"
X Link 2023-08-03T20:24Z 15.9K followers, [----] engagements
"On #BiotechHangout today @bradloncar @cngarabedian @SamFazeli8 @robperez32 & @eperlste discuss the influence of GLP-1s in light of $NVO positive study results & $LLY rising revenue data & regulatory news from $NVS $SAGE $NKTR/ $LLY $MRTX & Iveric plus $BLU $BNTX & $MRNA Q2 earnings $REGN buys $DBTX and Nasdaq threatens to delist $TSHA https://twitter.com/i/spaces/1jMJgLmBZOXxL https://twitter.com/i/spaces/1jMJgLmBZOXxL"
X Link 2023-08-11T12:58Z 15.9K followers, 10.2K engagements
"#BiotechHangout will be taking a break the next two weeks for the end of summer. Well be back after Labor Day on September 8th at 12pm ET"
X Link 2023-08-24T21:11Z 15.9K followers, [----] engagements
"Were back #BiotechHangout @daphnezohar @TheDawnBell @cngarabedian @BrianSkorney & guest @Frank_S_David talk data VC & crossover market dynamics hub & spoke funding (Apollo Nimbus & Star TX) $AMGN & $HZNP Nestle sells peanut allergy treatment it acquired for $2B+ for undisclosed amount $GMAB/ $SGEN $CBAY & $TNXP data $APLT stock price increase $OLMA financing & the [--] drugs for Medicare price negotiations https://twitter.com/i/spaces/1vOxwMdBQVmGB https://twitter.com/i/spaces/1vOxwMdBQVmGB"
X Link 2023-09-08T12:47Z 15.9K followers, 19.3K engagements
"#BiotechHangout hosts @daphnezohar @cngarabedian & @bradloncar spoke with @AlexWestchester during the @GENbio The State of Biotech event today where they discussed the latest in biotech business trends including market conditions #InflationReductionAct the impact of mental health and @BiotechTVHQ"
X Link 2023-09-13T20:57Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @daphnezohar @TimOpler @YaronWerber & @Seals310 + guest @gline talk $XBI sentiment $ICPT acquisition $ABBV/ $IMAB deal $GILD trial $APLS Favus report $IONS $MORF & $IMVT data $BHVN stock move on preclin data $BMS/ $AZN price negotiations + more https://twitter.com/i/spaces/1nAKEaOelnlKL https://twitter.com/i/spaces/1nAKEaOelnlKL"
X Link 2023-09-29T12:43Z 15.9K followers, 13.9K engagements
"On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @LifeSciVC @TheDawnBell and @MatteisPaul cover #CTAD23 #WorldSleepCongress Bipartisan biopharma initiatives being advanced in Congress OrbiMed $4.3B fund & are big VC rounds back $ROIV/$RHHBY Telavant acquisition CARGO IPO $BMY acquires rights from $LIAN Alzheimers news $NVS filing pushed @BernieSanders NIH investigation + middlemen impacting cancer care https://twitter.com/i/spaces/1lPKqbNZzLYGb https://twitter.com/i/spaces/1lPKqbNZzLYGb"
X Link 2023-10-27T14:36Z 15.9K followers, 12.7K engagements
"On todays #BiotechHangout @daphnezohar @gline @biotech1 @TimOpler @cngarabedian & @BrianSkorney discuss $SNY big drop + pharma stock performance $SRPT trial miss $LLY/ $BEAM agreement $CRSP/ $VRTX adcomm $PFE cost cuts $AMGN discontinues PSMA BiTE new investment funds (Abingworth $OWL Bioluminescence Ventures Sofinnova Partners) Lexeo $113M IPO $FDMT CF gene therapy $AZN $245M investment in $CLLS + more https://twitter.com/i/spaces/1dRJZEwjBAMGB https://twitter.com/i/spaces/1dRJZEwjBAMGB"
X Link 2023-11-03T13:20Z 15.9K followers, 13.7K engagements
"On #BiotechHangout today @daphnezohar @TimOpler @biotech1 @cngarabedian @JMaraganore & @eperlste cover #JefferiesHealthcare + @Stifel Healthcare conf takeaways CAR-T data updates at #ACR23 $AJINY acquires Forge ($620M) $GILD/ Arcellx partnership $ALKS spins out $MURA mergers including: Lenz/ $GRPH Q32 Bio/ $FIXX + $SELB/ $RNAC plus $CRSP/ $VRTX MHRA approval $VERV Ph1b data $PRTC Ph2a data $NVO trial risk reduction $MRK P2XH inhibitor briefing docs Astellas/ Propella $175M acquisition + more https://twitter.com/i/spaces/1BRKjPDajaLJw https://twitter.com/i/web/status/1725520299486032022"
X Link 2023-11-17T14:24Z 15.9K followers, 15.4K engagements
"On #BiotechHangout today @daphnezohar @bradloncar @JMaraganore @biotech1 @LifeSciVC & @YaronWerber cover $ABBV / $IMGN $10B acquisition FDAs CAR-T safety concerns data setbacks & wins ( $ROIV $ARGX $XENE & $IVMT) $REGN & $SNY seek to expand Dupixent approval to COPD $SWTX approval plus @JAMAInternalMed paper calls to eliminate orphan drug exemptions $SLRN & $BIVI point to CRO errors in trial failures X Prize $101M prize in aging + financings/biotech sentiment https://twitter.com/i/spaces/1vOxwjmLZeLJB https://twitter.com/i/spaces/1vOxwjmLZeLJB"
X Link 2023-12-01T14:01Z 15.9K followers, 18.5K engagements
"Were excited to once again be hosting our #Tweetup #Xup #BiotechHangout event at #JPM24 thanks to our sponsors @JNJNews @PureTechH @FTIConsulting @PointCross_LS @BancofCal & @misprobiotech Meet us at Persona (same location as last year) on Tuesday January 9th from 7-10pm. RSVP now to be sure youre on the list https://bit.ly/47Tr370 https://bit.ly/47Tr370"
X Link 2023-12-13T15:07Z 15.9K followers, [----] engagements
"Wishing everyone a safe and happy holiday season Biotech Hangout will return on January 5th. In the meantime we invite you to register for our #Tweetup #Xup #JPM24 event on January 9th - all made possible thanks to our sponsors @JNJNews @PureTechH @FTIConsulting @PointCross_LS @BancofCal & @misprobiotech https://bit.ly/47Tr370 https://bit.ly/47Tr370"
X Link 2023-12-21T13:40Z 15.9K followers, 29.9K engagements
"Were just [--] week away from the #BiotechHangout #Tweetup #Xup event at #JPM24 We have some of the best of #BioTwitter attending. Hope to see you IRL on Tues Jan [--] at Persona Be sure to RSVP: https://bit.ly/47Tr370 https://bit.ly/47Tr370"
X Link 2024-01-02T19:33Z 15.9K followers, [----] engagements
"Get ready for the #JPM24 scavenger hunt If you see these people anywhere in San Fran (including enroute on your flight) take a pic w/ them & tag us. Hint: many on the list might be found mingling at our #BiotechHangout #Tweetup #Xup so dont forget to RSVP. Winners will be announced at the event: http://bit.ly/47Tr370 http://bit.ly/47Tr370"
X Link 2024-01-04T18:53Z 15.9K followers, 10.9K engagements
"#BiotechHangout is back this week w/ @daphnezohar @biotech1 @TimOpler @PeterKolchinsky @MatteisPaul & @luba_greenwood to catch up on the news including end of year M&A from $BMY/ $KRTX $BMY/ $RYZB & $AZN/ Gracell FDA approves $AZN/ $IONS treatment & puts $IOVA therapy on hold $LBPH & $DYN data $NVS/ $VYGR collab $GS life science investment $IBRX financing RA Capitals latest sector analysis + [----] outlook sentiment hot areas & big picture issues & debate https://twitter.com/i/spaces/1rmxPMVnnAdKN https://twitter.com/i/spaces/1rmxPMVnnAdKN"
X Link 2024-01-05T14:18Z 15.9K followers, 10.3K engagements
"Our #Biotwitter friends filled the room at the #BiotechHangout #Tweetup #Xup tonight Our scavenger hunt is going strong with so many great photos captured so far. The winners will be announced later this week #JPM24"
X Link 2024-01-10T04:27Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @SamFazeli8 & @TheDawnBell discuss #JPM24 takeaways deals: $MRK/ $HARP $JNJ/ $AMAM $GSK/ Aiolos $BSX/ $AXNX + $NVS deal spree ( $CYTK Calypso Biotech Shanghai Argo $LLY/Isomorphic) plus Metagenomi & ArriVent preclinical IPOs $KYMR offering $ALPMY CRL $VRTX pauses trial & more https://twitter.com/i/spaces/1ZkKzjQAEVoKv https://twitter.com/i/spaces/1ZkKzjQAEVoKv"
X Link 2024-01-12T14:08Z 15.9K followers, 13.9K engagements
"Thanks again to everyone who attended our #BiotechHangout #Tweetup #Xup event & participated in the scavenger hunt. @US_FDA commissioner Rob Califf plus Rick Pierce & Peter Marschel from Decoy Therapeutics author @angelosgeo @MereoBioPharma CEO @ScotsKnight2 $EXAI's @drrichjlaw plus hosts @daphnezohar @bradloncar @biotech1 @JMaraganore & @eperlste amongst others were captured in photos as part of the hunt. Shoutout to @mpreminger @luba_greenwood @DeborahMoorad & @julie_norville for some great posts"
X Link 2024-01-12T21:33Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @daphnezohar @biotech1 @bradloncar @JMaraganore & @ColonGraceE cover $KYTX & other IPO filings eg $CGON Alto Neuroscience and digital biomarkers (FDA clears AI Alzheimers predictor & AI programs for diagnosing IPF) $BBIO secures capital from $OWL & Canada Pension Plan Investments FDA expands $VRTX & $CRSP's Cagevy $RGNX data Vivek Ramaswamy out of US pres. race Wiley Chambers retires plus early stage funding & what investors should do better https://twitter.com/i/spaces/1yoKMwmmwWDJQ https://twitter.com/i/spaces/1yoKMwmmwWDJQ"
X Link 2024-01-19T14:01Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @bradloncar @TimOpler @luba_greenwood & @BrianSkorney discuss $KURA $DNTH $ORIC & $OTLK private placements $CYTK $LLY & $IONS data PIPES/FOs $AMGN & other FDA black box warnings $SNY buys $INBX measles surge How CAR-T relates to metabolism $MRK/ $UNP collab $AVBP prices IPO $GILD Ph3 study FDA approves $JNJ's Balversa & finds manuf lapses at $LLY plus House Ways and Means Committee approves restoration of R&D tax credit https://twitter.com/i/spaces/1LyGBnZnebaGN https://twitter.com/i/spaces/1LyGBnZnebaGN"
X Link 2024-01-26T13:53Z 15.9K followers, 12K engagements
"On todays #BiotechHangout @daphnezohar @biotech1 @TimOpler @cngarabedian & @ColonGraceE cover the IPO market including $AUTL $SANA $MLYS $TNYA & $KYTX s upsized IPO $NVS to acquire $MOR for $2.9B $GILD walks away from Tizona deal data from $LLY $AMGN $FDMT $JNJ & $VRTX plus $GILD & $LLY drug discontinuations Novo Holdings to acquire $CTLT in $16.5B deal @US_FDA AI for drug surveillance Scion Life Sciences launches w/$310M fund & more: https://twitter.com/i/spaces/1YqxoDZNLyBKv https://twitter.com/i/spaces/1YqxoDZNLyBKv"
X Link 2024-02-09T14:15Z 15.9K followers, [----] engagements
"@EricSchmidt151 .@TimOpler talks about the financial raises from $CRSP and $SANA this week saying hats off to $SANA for being terrific engineers of allogeneic cells and innovating around removing the immune response to those cells. #BiotechHangout"
X Link 2024-02-16T17:38Z 15.9K followers, [---] engagements
".@daphnezohar notes that one thing we havent seen a lot of is companies winding down & returning capital to shareholders. This week we saw two cases 1) $MACKs plan to distribute the proceeds of this weeks $225M milestone payment from $IPSEY following FDA approval of their product to the companys shareholders and 2) LianBio announcing they are winding down and the board declared a special cash dividend of $528M or $4.80 per ordinary share. #BiotechHangout https://twitter.com/i/web/status/1758549394473750676 https://twitter.com/i/web/status/1758549394473750676"
X Link 2024-02-16T17:50Z 15.9K followers, [---] engagements
"On todays #BiotechHangout @daphnezohar @bradloncar @biotech1 @EricSchmidt151 @YaronWerber discuss FDA news: $IOVA s Amtagvi approval fast track for $IONS & $AZN s eplontersen $SRPT s Elevidys label expansion review two $RAPT drug trials on hold $UTHR litigation & $ALNY s ATTR trial endpoint changes plus FTC challenges & new roadblocks for $ABBV $CERE $ABBV CEO retires IQVIAs global R&D trends report Bayer cuts dividend by 95% $REGN & $VRTX cross $100B market cap threshold @Stifel reports R&D stage pharma up 19.8% outperformance of secondary offerings & IPOs & more:"
X Link 2024-02-23T13:52Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @bradloncar @biotech1 @cngarabedian @ColonGraceE @EricSchmidt151 discuss data from $RHHBYs Ph3 Enspryng gMG trial & $CRNX Ph3 Paltusotine trial $AZN acq of $FUSN & the radiopharm space Mirador launch (former Prometheus team) & megarounds rare disease news: newly approved Lenmedlys $4.25M price tag creation of Orphan Therapeutics Accelerator & lobbying exceptions for orphan drugs plus this weeks executive order on womens health research BIOs position reversal on BioSecure Act and more: https://twitter.com/i/spaces/1OyJAWABYzNKb"
X Link 2024-03-22T13:04Z 15.9K followers, [----] engagements
"On #BiotechHangout today @cngarabedian @biotech1 @TheDawnBell @MatteisPaul @YaronWerber discuss this weeks deals in the ADC space: $GMAB/Profound Bio $IPSEY/ $STRO & Merck/Caris more big private deals: Metsera Oruka Obsidian Alterome Neurosterix & Contineum also data from $ROIV $GRTS Verve LENZ & $VRTX plus Amylyx pulls ALS drug from market $ACOR & Eiger bankruptcies & more: https://twitter.com/i/spaces/1YqxoDmeAzzKv https://twitter.com/i/web/status/1776233725472247889 https://twitter.com/i/spaces/1YqxoDmeAzzKv https://twitter.com/i/web/status/1776233725472247889"
X Link 2024-04-05T13:01Z 15.9K followers, [----] engagements
"@cngarabedian @biotech1 @TheDawnBell @MatteisPaul @YaronWerber @bradloncar @daphnezohar @LifeSciVC @SamFazeli8 @luba_greenwood @TimOpler @mpreminger @JMaraganore Kicking off a big week of private deals @TheDawnBell discusses Metsera coming out of stealth with $350M and how their GLP-1 pipeline is as robust or more robust than some of the other leaders in the anti-obesity space. #BiotechHangout"
X Link 2024-04-05T16:08Z 15.9K followers, [---] engagements
"On todays #BiotechHangout @bradloncar @daphnezohar @luba_greenwood @EricSchmidt151 discuss inflation effects on biotech stocks more fallout from the BioSecure Act #AACR2024 $VRTX acquisition of $ALPN for $4.9B in cash $NVS pays $150M for $ARVNs prostate cancer therapy US govt lawsuit against $REGN LSE challenges w/ companies delisting and leaving @AAMortazavi joins us some big personnel moves $XBI and more https://twitter.com/i/spaces/1ynJOyVwPmzKR https://twitter.com/i/spaces/1ynJOyVwPmzKR"
X Link 2024-04-12T13:14Z 15.9K followers, 10.7K engagements
"On todays #BiotechHangout @cngarabedian @biotech1 @TimOpler @JMaraganore share their perspectives on PIPES supply/demand of venture capital & @nytimes article on WuXi plus discuss $DNA & $ADAP end collab Future Pak to acquire $VNDA $SNY divests Amuniz & $REGN builds venture arm data: $RARE $BHVN $SAGE $LLY $RHHBY & $NVS also $CGEM expands into autoimmune diseases Baker Bros returns $10b to shareholders Humira biosimilar grabs market share & much more: https://twitter.com/i/spaces/1kvJpvWnargKE https://twitter.com/i/spaces/1kvJpvWnargKE"
X Link 2024-04-19T12:58Z 15.9K followers, 10.7K engagements
"On todays #BiotechHangout @biotech1 @bradloncar @TimOpler @EricSchmidt151 @SamFazeli8 @JacobPlieth @ByMadeleineA cover #ASCO24 highlights shifting pharma oncology interests more data: $LLY $AGIO $ANNX $AMGN plus competitive dynamics: $GPCR vs the big leagues $BBIO / $BMRN $CRNX / $NBIX $VIR / $GILD Lykos ad comm Hengrui Form [---] II voting season the latest on Biosecure M&A sector/macro highlights & much more: https://twitter.com/i/spaces/1djGXNPErEjxZ https://twitter.com/i/spaces/1djGXNPErEjxZ"
X Link 2024-06-07T12:55Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @cngarabedian @bradloncar @TimOpler @TheDawnBell @JMaraganore @EricSchmidt151 dig into the obesity market w/ a look at @Stifels report & key findings $PFEs once daily oral GLP-1 report on patients discontinuing GLP-1 drugs in [--] yrs & GLP-1s for obesity-related cancers plus deals of the week: $LLY to acquire $MORF for $3.2B & Flagships $3.6B fund clinical readouts: $RHHBYs TIGIT study $QUREs Huntingtons data $IDYAs MAT2A data and @evaluatepharmas World Preview report & pharma forecast & more: https://twitter.com/i/spaces/1gqGvNkPlBRGB"
X Link 2024-07-12T13:01Z 15.9K followers, [----] engagements
"https://x.com/i/spaces/1yoKMyveRERKQ https://x.com/i/spaces/1yoKMyveRERKQ"
X Link 2024-07-19T15:57Z 15.9K followers, [----] engagements
"Lower the price and also upsize. Very odd $ARTV Any thoughts Allocation strategy probably also could have used more thought. https://www.globenewswire.com/news-release/2024/07/18/2915688/0/en/Artiva-Biotherapeutics-Announces-Pricing-of-Upsized-167-0-Million-Initial-Public-Offering.html AutoImmune Cell Therapy - what is it worth: all eyes on the $ARTV IPO today. Nothing like a little old fashioned price discovery to keep you entertained on a Friday. 🔘Kyverna Therapeutics: Their early clinical findings in multiple sclerosis (currently Phase 2) have shown https://t.co/KJeEuIvz8g"
X Link 2024-07-20T13:48Z 15.9K followers, [----] engagements
"Were excited to announce well once again be hosting our #BiotechHangout meetup at #JPM25 at Persona on Tuesday January 14th from 7-10pm. Interested in sponsoring the event Email team@biotechhangout.com for details Limited sponsorship spots available. Stay tuned for registration info"
X Link 2024-12-03T13:39Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @cngarabedian @biotech1 (Josh Schimmer) @t_lorriman @SamFazeli8 & @ceesay_abe discuss recent deals: $PTCT/$NVS $OLMA/$NVS $PSTX/Roche data: $AMGNs Maritide $LLY/$NVO head-to-head trial Roches TIGIT Ph3 results plus $SNTI $CGON $NVCR/$ZLAB $JANX data & other oncology movers: $RVMD & $NVCR & more topics including executive security latest insights on Trump nominees CNS outlook & more: https://twitter.com/i/spaces/1vAGROWBAMaJl https://twitter.com/i/spaces/1vAGROWBAMaJl"
X Link 2024-12-06T13:56Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @Biotech1 (Josh Schimmer) @YaronWerber @BrianSkorney @t_lorriman @EricSchmidt151 cover macro news of the week: new FTC head & what it means for M&A biopharma not challenging RFK Jr BioSecure Act missing from Defense Bill Luigi Mangiones arrest plus #ASH24 highlights: CAR-T battle: $ACLX/GILD vs $LGND/$JNJ $AGIO & other SCD cell therapies updates Blenreps return BTK degraders ($BGNE $NRIX) plus other news: $RVNC/Crown deal big movers: $CMRX $CDAL $QURE & updates from $RLAY $TRML $KRYS $KROS & more: https://twitter.com/i/spaces/1mrxmMrMWdvxy"
X Link 2024-12-13T13:55Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @cngarabedian @bradloncar @SamFazeli8 @YaronWerber discuss the state of the market & recap EOY reports $XBI outlook #JPM25 preview $GLGP splits in [--] $PFE YE update & Part D Redesign changes Novo/Valo Health deal & more China deals bird flu death & impact on stocks have we reached peak obesity plus $STOK moves to Ph3 for Dravet $JSPR & $VIR data & much more: https://twitter.com/i/spaces/1djGXrldzpExZ https://twitter.com/i/spaces/1djGXrldzpExZ"
X Link 2025-01-10T13:54Z 15.9K followers, [----] engagements
"We look forward to seeing everyone tonight at Persona (685 Sutter St) for the #BiotechHangout @BiotechTVHQ networking event Open bar begins at 7pm thanks to our sponsors @JNJNews @misprobiotech @FTIConsulting @hellocatalytic @PureTechH : Join us in person for the @BiotechCH @BiotechTVHQ hangout from 7:00 to 10:00. All are welcome to attend. Stop by https://t.co/k5jCi9l8F3 : Join us in person for the @BiotechCH @BiotechTVHQ hangout from 7:00 to 10:00. All are welcome to attend. Stop by https://t.co/k5jCi9l8F3"
X Link 2025-01-14T20:06Z 15.9K followers, 11.4K engagements
"Hanging out with @bradloncar @daphnezohar @TimOpler and Josh Schimmer at the #biotechhangout #tweetup. Share some pictures & tag us and we will share"
X Link 2025-01-15T03:44Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @cngarabedian @TimOpler @SamFazeli8 @BrianSkorney @luba_greenwood discuss public market sentiment capital markets & the IPO backlog Trumps latest moves: NIH WHO FDA hiring freeze immigration impact AI in healthcare: Stargate AI $RXRX Agenetic AI plus cancer vaccines the deal market Biogen R&D cuts $NVOs amycretin obesity drug data recent Nature paper on GLP-1 drugs effects & more: https://twitter.com/i/spaces/1YqGovvoMQyKv https://twitter.com/i/spaces/1YqGovvoMQyKv"
X Link 2025-01-24T14:03Z 15.9K followers, [----] engagements
"On todays #BiotechHangout hosts @bradloncar @EricSchmidt151 @t_lorriman @luba_greenwood @TimOpler are joined by @adamfeuerstein to discuss zombie biotechs & the news of the week: $BIIB / $STOK deal $SLDB DMD gene therapy data & fundraising dynamics $SWTX buyout rumors $BLUE acquisition $SEPN drops lead asset $FGEN China deal $BBIO Attruby launch Formycon earnings glp1 compounding $HIMS soars & why doesnt Novo sue for patent infringement plus a look at deal activity shifts in pharma priorities cash flow investing market mood 13f filings & fund returns & much more:"
X Link 2025-02-21T14:03Z 15.9K followers, 11.5K engagements
"Why does anyone listen to Betaville They constantly put out false rumors. Likely leaked by the banks trying to push a deal through. Even a broken clock is right twice a day if only we had any m&a let alone 1/20 of what bettaville claims if only we had any m&a let alone 1/20 of what bettaville claims"
X Link 2025-02-22T13:24Z 15.9K followers, 21.1K engagements
"On todays #BiotechHangout @daphnezohar @EricSchmidt151 @t_lorriman @BrianSkorney @YaronWerber discuss market/investor blues #TDCowen Conf takeaways deals ($JAZZ + $CMRX $ABBV + $GUBRAMerck KgaA + $SWTX) data ($PLRX halts Ph2b IPF study $BHVNs promising Ph1 results for BHV-1300 $BMY scraps G12D inhibitor from $MRTX deal) RFK Jr.s #measles response Senate hearings for NIH/FDA Conflicts of interest incl. $PFE Cavazzoni from last week) networking dos & donts etc: https://x.com/i/spaces/1rmGPylBleEJN/peek https://x.com/i/spaces/1rmGPylBleEJN/peek"
X Link 2025-03-07T14:02Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @EricSchmidt151 @SamFazeli8 @YaronWerber are joined by @IAmBiotechs John Crowley to discuss BIOs near-term priorities how biopharma is working w/the new administration & status of the FDA plus news of the week including obesity updates: $NVOs CagriSema data $ZEAL + Roche deal $VKTX manufacturing deal & other news: key $AMGN Uplizna data at #AAN2025 heats up space small cap oncology acquisition trends w/ Sun Pharma / $CKPT $BMY / $TSVT deals $SWTX/Merck KgaA - deal or no deal earnings recaps: $BNTX & & $LEGN & more: https://twitter.com/i/spaces/1lPKqMPYklYKb"
X Link 2025-03-14T13:06Z 15.9K followers, 11.1K engagements
"Biopharma Funds Are in Sick Bay (performance data) https://www.institutionalinvestor.com/article/2ej1odwnbkz58mdfdgpvk/biopharma-funds-are-in-sick-bay https://www.institutionalinvestor.com/article/2ej1odwnbkz58mdfdgpvk/biopharma-funds-are-in-sick-bay"
X Link 2025-03-24T15:04Z 15.9K followers, 15.9K engagements
"https://x.com/i/spaces/1MYxNwQwXvQKw https://x.com/i/spaces/1MYxNwQwXvQKw"
X Link 2025-03-28T15:57Z 15.9K followers, 25.4K engagements
"On DCF @EricSchmidt151 thinks that valuation is a fools game. Its garbage in and garbage out. Its black and white - what matters is if the drug works or notWe should spend a lot less time as a community working out models that are fictitious and a lot more time doing due diligence on what's going to work. #BiotechHangout"
X Link 2025-06-13T17:14Z 15.9K followers, 20.4K engagements
"#BiotechHangout is taking a break this week and will be back on Friday June [--]. Have a great weekend"
X Link 2025-06-19T13:00Z 15.9K followers, [----] engagements
"On today's #BiotechHangout @cngarabedian @daphnezohar @SamFazeli8 @MatteisPaul @t_lorriman & @TimOpler discuss market sentiment #BIO2025 recap & BIOs top priorities FDA listening tour & Makary's potential role in $KALVs rejection request ACIP meeting recap new CDER head China healthcare & future U.S.-China relations #ADA25: $LLYs updates $NVO's Amycretin & CagriSema Regor's oral RGT-075 $MTSR $NVO/$HIMS cancellation & fallout plus other data news: $CDTX's antiviral biologic $CMPS Ph3 psilocybin readout $NKTR Ph2b in atopic dermatitis $SRPTs challenges $RVMD/$RPRX $2B flexible funding deal a"
X Link 2025-06-27T13:19Z 15.9K followers, 10.2K engagements
"On today's #BiotechHangout @ericschmidt151 @bradloncar @TimOpler & @t_lorrimancoverM&A: $MRK/$VRNA $ABBV/Capstan &a nod to the Biotech Sisterhood biotech takeouts by the numbersis this a biotechM&A waveOutlook for 2H25pharmas $150B in LOE approachingplus macro news: TrumpsBig Beautiful Bill and the latesttariffheadlines $XBI response & MFN rumorsstocks have recovered fromApril downturnis the outlookclearAnd onFDAfront: a group discussion on theCRL disclosures$CAPR DMD rejection plus$KALV approval $PROKs big move obesity trendsreport& $LLYs dominance $RARE/$MREO setbacks plus $ABBV/Ichnos deal"
X Link 2025-07-11T13:02Z 15.9K followers, [----] engagements
"Im an investment banker and Im working on more M&A right now than I ever have. Buyers are now shopping commercial and there's a very simple reason - you need revenue and you can buy revenue notes @TimOpler. With a growing pool of commercial-stage biotech companies the market remains competitive but with fewer bidders per deal keeping premiums modest. #BiotechHangout"
X Link 2025-07-11T16:38Z 15.9K followers, 33.7K engagements
"On todays #BiotechHangout @daphnezohar @biotech1 (Josh Schimmer) @BrianSkorney @MatteisPaul @SamFazeli8 & @gline will cover: Trump's letters to [--] pharmas re US drug pricing/MFN Prasad out at CBER good or bad for biotech CEO listening session w/ Makary & Tidmarsh RFK's plans (vaccine liability exposure U.S. Preventive Services Task Force) tariffs the latest $SRPT drama & management/board dynamics $GSK/Hengrui & China deals impact on $XBI $BMY/Bain spinco $GLPG restructuring $ABBV $1B Gilgamesh rumors long the launch: $ALNY $ARGX $NBIX data: Roche Alzheimer's study $LLY abeta prevention study"
X Link 2025-08-01T13:00Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @ColonGraceE @JMaraganore @MatteisPaul @EricSchmidt151 &@LifeSciVC will cover policy: RFK Jr. cancels mRNA vaccine contractslatest on MFN & Trumps pharma tariffs warning could Prasad come back $SRRK manufacturing debate data: $PRAX epilepsy update $VRTX in pain $AGIOs data & stock rollercoaster $PFE 3rd GLP-1 discontinuation $LLYs orforglipron results big pharma shifts: $NVO trims pipeline Bayer layoffs an earnings recap: $BBIO TGTX & $MDGL $MDGL licensing deal w/ China plus $NVO/$RNA deal rumors $YMAB acquisition $BIIBs venturesteam royalty markets ($XOMA OrbiMed)"
X Link 2025-08-08T13:02Z 15.9K followers, 10.8K engagements
"Mark your calendars #BiotechHangout & @BiotechTV are back again for our annual IRL networking event at #JPM26 Join us at Persona on Tuesday January 13thfrom 7-10pm for a chance to meet up with biotech friends. Interested in sponsoring the event Reach out toteam@biotechhangout.comfor more information. Additional registration information to come"
X Link 2025-10-21T13:15Z 15.9K followers, [----] engagements
"On todays #BiotechHangout @soowannaway (Graig Suvannavejh) @MatteisPaul @BrianSkorney @YaronWerber @cngarabedian & special guest @adamfeuerstein will cover policy & regulatory news: George Tidmarsh resigns from FDA $SRPT ESSENCE trial results & ties to FDA decisions FDA deems $QUREs #HuntingtonsDisease data inadequate & read throughs to $STOK ahead of #DravetSyndrome filing & Dec. FDA meeting $BHVN CRL plus: Arena BioWorks shuts down $NVO/$PFE bidding war for $MTSR escalates $SLNO Q3 earnings data: $CNTA & $HRMY #narcolepsy data $TERN up 90% on #CML data & much more:"
X Link 2025-11-07T14:00Z 15.9K followers, 13.6K engagements
"At #ASH25 $LLYs Jaypicra announced Ph3 data highlighting fierce competition in the BTK inhibitor space with $ONC & others. The data from $LLY is very early. In general it's supposed to be safer but the safety differences honestly ended up being a little marginal says @YaronWerber. Finally $ONC has a monster pipeline in CLL including a BCL2 inhibitor in combination and a BTK degrader. Frankly they've moved their BTK degrader now to be tested head-to-head against $LLYs drug. So this is going to be fireworks for a while. Bottom line is you could argue: $ONC is no longer the absolute leader."
X Link 2025-12-12T17:50Z 15.9K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::BiotechCH